1368488
2025
1
heidelberg-university-faculty-of-medicine
50
creator
asc
year
1
1723
https://cnrmyrma.fr/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22884FBB68%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Aguilar-P%5Cu00e9rez%20et%20al.%22%2C%22parsedDate%22%3A%222025-10-22%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAguilar-P%26%23xE9%3Brez%2C%20C.%2C%20Lenaerts%2C%20A.%20J.%2C%20Villellas%2C%20C.%2C%20Guillemont%2C%20J.%2C%20Dallow%2C%20J.%2C%20Painter%2C%20H.%2C%20Ammerman%2C%20N.%20C.%2C%20Hassan%2C%20A.%2C%20Golovkine%2C%20G.%2C%20Brock%2C%20L.%2C%20Sordello%2C%20S.%2C%20Chauffour%2C%20A.%2C%20Aubry%2C%20A.%2C%20Mai%2C%20T.%20C.%2C%20Wong%2C%20S.%2C%20Clark%2C%20T.%20G.%2C%20Nam%2C%20K.%2C%20Kim%2C%20J.%2C%20Choi%2C%20J.%2C%20Crabbe%2C%20M.%2C%20Esquivias%2C%20J.%2C%20Lounis%2C%20N.%2C%20Stoops%2C%20B.%2C%20Amssoms%2C%20K.%2C%20Bartolome-Nebreda%2C%20J.%20M.%2C%20Gruppo%2C%20V.%2C%20Robertson%2C%20G.%20T.%2C%20Veziris%2C%20N.%2C%20Upton%2C%20A.%20M.%2C%20Nuermberger%2C%20E.%20L.%2C%20Cox%2C%20V.%2C%20Ballell%2C%20L.%2C%20Baeten%2C%20B.%2C%20Koul%2C%20A.%2C%20Pym%2C%20A.%20S.%2C%20Wall%2C%20R.%20J.%20and%20Lamprecht%2C%20D.%20A.%20%282025%29.%20%26lt%3Bb%26gt%3BThe%20role%20of%20cytochrome%20bc1%20inhibitors%20in%20future%20tuberculosis%20treatment%20regimens%26lt%3B%5C%2Fb%26gt%3B.%20Nat%20Commun%20%26lt%3Bi%26gt%3B16%26lt%3B%5C%2Fi%26gt%3B%2C%209344%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41467-025-64427-6%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41467-025-64427-6%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20role%20of%20cytochrome%20bc1%20inhibitors%20in%20future%20tuberculosis%20treatment%20regimens%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clara%22%2C%22lastName%22%3A%22Aguilar-P%5Cu00e9rez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%20J.%22%2C%22lastName%22%3A%22Lenaerts%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cristina%22%2C%22lastName%22%3A%22Villellas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jerome%22%2C%22lastName%22%3A%22Guillemont%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Dallow%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hannah%22%2C%22lastName%22%3A%22Painter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%20C.%22%2C%22lastName%22%3A%22Ammerman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anis%22%2C%22lastName%22%3A%22Hassan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guillaume%22%2C%22lastName%22%3A%22Golovkine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laure%22%2C%22lastName%22%3A%22Brock%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvie%22%2C%22lastName%22%3A%22Sordello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aur%5Cu00e9lie%22%2C%22lastName%22%3A%22Chauffour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thi%20Cuc%22%2C%22lastName%22%3A%22Mai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Wong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Taane%20G.%22%2C%22lastName%22%3A%22Clark%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kiyean%22%2C%22lastName%22%3A%22Nam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeongjun%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jinho%22%2C%22lastName%22%3A%22Choi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marjolein%22%2C%22lastName%22%3A%22Crabbe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jorge%22%2C%22lastName%22%3A%22Esquivias%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nacer%22%2C%22lastName%22%3A%22Lounis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bart%22%2C%22lastName%22%3A%22Stoops%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katie%22%2C%22lastName%22%3A%22Amssoms%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jose%20M.%22%2C%22lastName%22%3A%22Bartolome-Nebreda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Veronica%22%2C%22lastName%22%3A%22Gruppo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%20T.%22%2C%22lastName%22%3A%22Robertson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%20M.%22%2C%22lastName%22%3A%22Upton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%20L.%22%2C%22lastName%22%3A%22Nuermberger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vivian%22%2C%22lastName%22%3A%22Cox%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lluis%22%2C%22lastName%22%3A%22Ballell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benny%22%2C%22lastName%22%3A%22Baeten%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anil%22%2C%22lastName%22%3A%22Koul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%20S.%22%2C%22lastName%22%3A%22Pym%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20J.%22%2C%22lastName%22%3A%22Wall%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dirk%20A.%22%2C%22lastName%22%3A%22Lamprecht%22%7D%5D%2C%22abstractNote%22%3A%22Abstract%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Tuberculosis%20%28TB%29%20remains%20the%20foremost%20cause%20of%20death%20from%20infectious%20diseases%20globally%2C%20prompting%20ongoing%20efforts%20to%20improve%20treatment%20options.%20This%20includes%20developing%20compounds%20with%20novel%20modes%20of%20action%20and%20identifying%20optimal%20treatment%20regimens%20that%20allow%20for%20treatment%20shortening.%20One%20promising%20strategy%20involves%20targeting%20cytochrome%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20bc%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%201%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20oxidase%20in%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Mycobacterium%20tuberculosis%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%2C%20a%20key%20enzyme%20in%20the%20respiratory%20chain.%20In%20this%20study%2C%20we%20evaluate%20the%20potential%20of%20cytochrome%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20bc%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%201%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20inhibitors%20as%20partner%20drugs%20in%20TB%20combination%20regimens.%20Using%20a%20relapsing%20mouse%20model%2C%20we%20demonstrate%20that%20these%20inhibitors%20enhance%20regimen%20sterilisation%20and%20significantly%20reduce%20the%20time%20required%20for%20effective%20treatment.%20We%20also%20propose%20several%20novel%20combination%20strategies%20for%20both%20multidrug-resistant%20and%20drug-sensitive%20TB%2C%20where%20cytochrome%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20bc%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%201%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20inhibitors%20contribute%20to%20sterilisation%20and%20improved%20treatment%20outcomes.%20Furthermore%2C%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20M.%20tuberculosis%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20clinical%20isolates%20exhibited%20heightened%20susceptibility%20to%20cytochrome%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20bc%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%201%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20inhibitors%20compared%20to%20laboratory-adapted%20strains%2C%20highlighting%20the%20importance%20of%20using%20clinical%20isolates%20in%20TB%20drug%20discovery%20to%20better%20reflect%20the%20diversity%20of%20TB%20populations.%20These%20findings%20emphasise%20the%20potential%20of%20cytochrome%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20bc%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%201%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20inhibition%20in%20the%20development%20of%20more%20effective%20and%20shorter%20treatment%20regimens%20for%20TB%2C%20supporting%20the%20need%20for%20further%20clinical%20investigation.%22%2C%22date%22%3A%222025-10-22%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41467-025-64427-6%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41467-025-64427-6%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%222041-1723%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-12-26T10%3A36%3A53Z%22%7D%7D%2C%7B%22key%22%3A%22BFLEGPH2%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Allam%20et%20al.%22%2C%22parsedDate%22%3A%222025%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAllam%2C%20C.%2C%20Haenn%2C%20S.%2C%20Giraud%2C%20E.%2C%20Awad%2C%20Z.%2C%20Robert%2C%20J.%2C%20Cambau%2C%20E.%2C%20Moulin%2C%20L.%20and%20Mougari%2C%20F.%20%282025%29.%20%26lt%3Bb%26gt%3BStandardised%20protocol%20for%20the%20detection%20and%20quantification%20of%20nontuberculous%20mycobacteria%20%28NTM%29%20in%20tap%20water%20and%20its%20application%20in%20investigating%20the%20source%20of%20NTM%20clinical%20infections%26lt%3B%5C%2Fb%26gt%3B.%20International%20Journal%20of%20Hygiene%20and%20Environmental%20Health%20%26lt%3Bi%26gt%3B268%26lt%3B%5C%2Fi%26gt%3B%2C%20114618%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ijheh.2025.114618%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ijheh.2025.114618%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Standardised%20protocol%20for%20the%20detection%20and%20quantification%20of%20nontuberculous%20mycobacteria%20%28NTM%29%20in%20tap%20water%20and%20its%20application%20in%20investigating%20the%20source%20of%20NTM%20clinical%20infections%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Camille%22%2C%22lastName%22%3A%22Allam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sophie%22%2C%22lastName%22%3A%22Haenn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emma%22%2C%22lastName%22%3A%22Giraud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zeina%22%2C%22lastName%22%3A%22Awad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00e9r%5Cu00f4me%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurent%22%2C%22lastName%22%3A%22Moulin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fa%5Cu00efza%22%2C%22lastName%22%3A%22Mougari%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2207%5C%2F2025%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ijheh.2025.114618%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS1438463925001002%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%2214384639%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-09-30T14%3A59%3A58Z%22%7D%7D%2C%7B%22key%22%3A%227N5LTZQU%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Benhard%20et%20al.%22%2C%22parsedDate%22%3A%222025-07-31%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBenhard%2C%20J.%2C%20Monsel%2C%20G.%2C%20Dub%26%23xE9%3Be%2C%20V.%2C%20Pavese%2C%20P.%2C%20Rasoldier%2C%20V.%2C%20Garrait%2C%20V.%2C%20Talleux%2C%20M.%2C%20Vuotto%2C%20F.%2C%20Gueneau%2C%20R.%2C%20Pouget-Abadie%2C%20X.%2C%20Thy%2C%20M.%2C%20Palacios%2C%20C.%2C%20Bachir%2C%20M.%2C%20Djossou%2C%20F.%2C%20Tunesi%2C%20S.%2C%20Jachym%2C%20M.%20F.%2C%20Pourcher%2C%20V.%2C%20Veziris%2C%20N.%20and%20Bourgarit%2C%20A.%20%282025%29.%20%26lt%3Bb%26gt%3BStandardized%20Infliximab%20Regimen%20to%20Treat%20Severe%20Central%20Nervous%20System%20Tuberculosis%3A%20A%20Case%20Series%20of%2018%20Patients%26lt%3B%5C%2Fb%26gt%3B.%20Open%20Forum%20Infectious%20Diseases%20%26lt%3Bi%26gt%3B12%26lt%3B%5C%2Fi%26gt%3B%2C%20ofaf450%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fofid%5C%2Fofaf450%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fofid%5C%2Fofaf450%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Standardized%20Infliximab%20Regimen%20to%20Treat%20Severe%20Central%20Nervous%20System%20Tuberculosis%3A%20A%20Case%20Series%20of%2018%20Patients%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johan%22%2C%22lastName%22%3A%22Benhard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gentiane%22%2C%22lastName%22%3A%22Monsel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Dub%5Cu00e9e%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patricia%22%2C%22lastName%22%3A%22Pavese%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vero%22%2C%22lastName%22%3A%22Rasoldier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Val%5Cu00e9rie%22%2C%22lastName%22%3A%22Garrait%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Talleux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fanny%22%2C%22lastName%22%3A%22Vuotto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Romain%22%2C%22lastName%22%3A%22Gueneau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xavier%22%2C%22lastName%22%3A%22Pouget-Abadie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Thy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christia%22%2C%22lastName%22%3A%22Palacios%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marwa%22%2C%22lastName%22%3A%22Bachir%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Felix%22%2C%22lastName%22%3A%22Djossou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simone%22%2C%22lastName%22%3A%22Tunesi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mathilde%20Fr%5Cu00e9chet%22%2C%22lastName%22%3A%22Jachym%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Val%5Cu00e9rie%22%2C%22lastName%22%3A%22Pourcher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Bourgarit%22%7D%5D%2C%22abstractNote%22%3A%22Abstract%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Background%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Morbidity%20associated%20with%20central%20nervous%20system%20tuberculosis%20%28CNS%20TB%29%20remains%20high%20due%20to%20persistent%20inflammation%20despite%20standard-of-care%20%28SOC%29%20treatment%2C%20including%20antituberculosis%20therapy%20and%20corticosteroids.%20Tumor%20necrosis%20factor%20alpha%20%28TNF-%5Cu03b1%29%20is%20a%20key%20cytokine%20driving%20this%20inflammatory%20response%2C%20and%20a%20limited%20number%20of%20case%20reports%20suggest%20that%20TNF-%5Cu03b1%20inhibitors%20may%20improve%20outcomes.%20We%20report%20the%201-year%20outcome%20of%20a%20cohort%20of%20consecutive%20patients%20treated%20with%20infliximab%20for%20severe%20CNS%20TB.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Methods%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Following%20the%20guidance%20provided%20by%20the%20French%20Tuberculosis%20Consilium%2C%20a%20standardized%20regimen%20of%20intravenous%20infliximab%20at%205%5Cu2005mg%5C%2Fkg%20per%20dose%20was%20used%20to%20treat%20CNS%20TB%20unresponsive%20to%20SOC.%20We%20retrospectively%20included%20consecutive%20patients%20who%20received%20at%20least%201%20infliximab%20injection%20for%20CNS%20TB%20from%202017%20to%20September%202021.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Results%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Eighteen%20patients%20with%20CNS%20TB%2C%2094%25%20with%20tuberculous%20meningitis%2C%20were%20included.%20Most%20had%20severe%20disease%3A%2082%25%20were%20classified%20as%20British%20Medical%20Research%20Council%20grade%20II%20or%20III%2C%20and%2044%25%20required%20intensive%20care%20unit%20admission.%20All%20demonstrated%20clinical%20and%20radiological%20worsening%20despite%20SOC%3B%20in%2089%25%20due%20to%20paradoxical%20reaction.%20At%20infliximab%20initiation%2C%20symptoms%20remained%20disabling%2C%20with%20a%20median%20modified%20Rankin%20scale%20%28mRS%29%20score%20of%203.5%20%28interquartile%20range%2C%203%5Cu20134%29.%20One%20month%20after%20the%20first%20infusion%2C%2038%25%20showed%20improved%20mRS%20scores%2C%20increasing%20to%2078%25%20at%201%5Cu2005year.%20One-year%20survival%20was%2094%25%3B%201%20death%20occurred%2012%5Cu2005months%20after%20a%20single%20infliximab%20dose%20and%20was%20unrelated%20to%20TB%20treatment.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Conclusions%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Infliximab%20may%20represent%20a%20promising%20adjunctive%20treatment%20for%20CNS%20TB%20unresponsive%20to%20SOC%2C%20including%20paradoxical%20reaction.%20Prospective%20studies%20are%20needed%20to%20confirm%20these%20findings.%22%2C%22date%22%3A%222025-07-31%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1093%5C%2Fofid%5C%2Fofaf450%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Facademic.oup.com%5C%2Fofid%5C%2Farticle%5C%2Fdoi%5C%2F10.1093%5C%2Fofid%5C%2Fofaf450%5C%2F8232409%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%222328-8957%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-09-30T15%3A04%3A32Z%22%7D%7D%2C%7B%22key%22%3A%22P98GJIV5%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bonnet%20et%20al.%22%2C%22parsedDate%22%3A%222025-05-22%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBonnet%2C%20I.%2C%20Orgeur%2C%20M.%2C%20Brossier%2C%20F.%2C%20Sayes%2C%20F.%2C%20Frigui%2C%20W.%2C%20Madacki%2C%20J.%2C%20Varet%2C%20H.%2C%20Chauffour%2C%20A.%2C%20Aubry%2C%20A.%2C%20Veziris%2C%20N.%2C%20Sougakoff%2C%20W.%2C%20Brosch%2C%20R.%20and%20Tournebize%2C%20R.%20%282025%29.%20%26lt%3Bb%26gt%3BEvaluation%20of%20the%20role%20of%20%26lt%3Bi%26gt%3BwhiB6%26lt%3B%5C%2Fi%26gt%3B%20and%20%26lt%3Bi%26gt%3BkdpDE%26lt%3B%5C%2Fi%26gt%3B%20in%20the%20dominant%20multidrug-resistant%20clone%20%26lt%3Bi%26gt%3BMycobacterium%20tuberculosis%26lt%3B%5C%2Fi%26gt%3B%20B0%5C%2FW148%26lt%3B%5C%2Fb%26gt%3B%20Ed.%20Doucet-Populaire%2C%20F.%20C.%20Microbiol%20Spectr%20e03224-24%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2Fspectrum.03224-24%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2Fspectrum.03224-24%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Evaluation%20of%20the%20role%20of%20%3Ci%3EwhiB6%3C%5C%2Fi%3E%20and%20%3Ci%3EkdpDE%3C%5C%2Fi%3E%20in%20the%20dominant%20multidrug-resistant%20clone%20%3Ci%3EMycobacterium%20tuberculosis%3C%5C%2Fi%3E%20B0%5C%2FW148%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabelle%22%2C%22lastName%22%3A%22Bonnet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mickael%22%2C%22lastName%22%3A%22Orgeur%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fadel%22%2C%22lastName%22%3A%22Sayes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wafa%22%2C%22lastName%22%3A%22Frigui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jan%22%2C%22lastName%22%3A%22Madacki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hugo%22%2C%22lastName%22%3A%22Varet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aur%5Cu00e9lie%22%2C%22lastName%22%3A%22Chauffour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wladimir%22%2C%22lastName%22%3A%22Sougakoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roland%22%2C%22lastName%22%3A%22Brosch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R%5Cu00e9gis%22%2C%22lastName%22%3A%22Tournebize%22%7D%2C%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22Florence%20Claude%22%2C%22lastName%22%3A%22Doucet-Populaire%22%7D%5D%2C%22abstractNote%22%3A%22ABSTRACT%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20Multidrug-resistant%20%28MDR%29%20strains%20of%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20Mycobacterium%20tuberculosis%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20represent%20an%20obstacle%20to%20eradicating%20tuberculosis%20%28TB%29%20due%20to%20the%20low%20treatment%20success%20rate%20of%20MDR%20TB.%20Among%20them%2C%20the%20MDR%20B0%5C%2FW148%20clone%20has%20recently%20evolved%20from%20the%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20M.%20tuberculosis%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20Beijing%20lineage%202%20and%20is%20widely%20disseminated%20in%20Russia%20and%20Europe.%20To%20get%20more%20insights%20into%20the%20genetic%20factors%20underlying%20the%20evolutionary%20success%20of%20the%20MDR%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20M.%20tuberculosis%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20B0%5C%2FW148%20clone%20in%20addition%20to%20environmental%20and%20patient-related%20features%2C%20we%20focused%20on%20two%20mutations%20specific%20to%20this%20clone%20that%20are%20found%20in%20the%20transcriptional%20regulators%20WhiB6%20and%20KdpDE%20and%20investigated%20in%20a%20H37Rv%20strain%20background%20the%20transcriptional%20profile%20associated%20with%20these%20mutations%20and%20their%20impact%20on%20the%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20in%20vitro%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20and%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20in%20vivo%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20growth%20characteristics.%20Through%20the%20construction%20and%20use%20of%20H37Rv%5Cu2206%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20whiB6%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%2C%20H37Rv%5Cu2206%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20kdpDE%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%2C%20and%20complemented%20strains%2C%20neither%20mutation%20impaired%20the%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20in%20vitro%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20growth%20of%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20M.%20tuberculosis%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20in%20standard%20mycobacterial%20growth%20media.%20The%20mutation%20T51P%20in%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20whiB6%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20prevented%20the%20upregulation%20of%209%20genes%20in%20the%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20esx-1%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20core%20region%20and%2044%20genes%20elsewhere%20in%20the%20genome%2C%20while%20the%20deletion%20of%20two%20nucleotides%20in%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20kdpD%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20leads%20to%20a%20fusion%20protein%20of%20KdpD%20with%20KdpE%20that%20inhibits%20the%20transcriptional%20activity%20of%20KdpE.%20Neither%20mutation%20led%20to%20hypervirulence%20in%20a%20mouse%20infection%20model.%20These%20results%20point%20to%20the%20role%20of%20other%20MDR%20B0%5C%2FW148%20specific%20mutations%20in%20the%20wide%20geographic%20diffusion%20of%20this%20clone%20and%5C%2For%20put%20in%20question%20a%20hypothesized%20hypervirulence%20as%20a%20driving%20factor%20for%20this%20large%20dissemination.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20IMPORTANCE%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20Human%20tuberculosis%20%28TB%29%2C%20caused%20by%20the%20bacterium%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20Mycobacterium%20tuberculosis%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%2C%20remains%20a%20global%20public%20health%20issue%20estimated%20to%20have%20been%20responsible%20for%201.25%20million%20deaths%20in%202023.%20Multidrug-resistant%20%28MDR%29%20strains%20of%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20M.%20tuberculosis%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%2C%20resistant%20to%20rifampicin%20and%20isoniazid%2C%20lead%20to%20lower%20treatment%20success.%20Among%20them%2C%20the%20MDR%20B0%5C%2FW148%20clone%20has%20widely%20disseminated%20in%20Russia%20and%20Europe.%20To%20get%20more%20insights%20into%20the%20genetic%20factors%20underlying%20the%20evolutionary%20success%20of%20this%20clone%2C%20we%20investigated%20two%20strain-specific%20mutations%20found%20in%20the%20transcriptional%20regulators%20WhiB6%20and%20KdpDE.%20By%20constructing%20and%20analyzing%20laboratory%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20M.%20tuberculosis%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20strains%20carrying%20these%20specific%20mutations%2C%20we%20found%20numerous%20changes%20in%20their%20transcriptional%20profiles%2C%20whereas%20we%20observed%20only%20a%20little%20impact%20of%20these%20mutations%20on%20the%20virulence%20of%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20M.%20tuberculosis%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20in%20a%20mouse%20infection%20model.%20Our%20study%20provides%20new%20insights%20into%20the%20transcriptional%20landscape%20of%20the%20selected%20MDR%20strains%2C%20although%20no%20direct%20connection%20to%20virulence%20could%20be%20established.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%2C%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Human%20tuberculosis%20%28TB%29%2C%20caused%20by%20the%20bacterium%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Mycobacterium%20tuberculosis%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%2C%20remains%20a%20global%20public%20health%20issue%20estimated%20to%20have%20been%20responsible%20for%201.25%20million%20deaths%20in%202023.%20Multidrug-resistant%20%28MDR%29%20strains%20of%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20M.%20tuberculosis%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%2C%20resistant%20to%20rifampicin%20and%20isoniazid%2C%20lead%20to%20lower%20treatment%20success.%20Among%20them%2C%20the%20MDR%20B0%5C%2FW148%20clone%20has%20widely%20disseminated%20in%20Russia%20and%20Europe.%20To%20get%20more%20insights%20into%20the%20genetic%20factors%20underlying%20the%20evolutionary%20success%20of%20this%20clone%2C%20we%20investigated%20two%20strain-specific%20mutations%20found%20in%20the%20transcriptional%20regulators%20WhiB6%20and%20KdpDE.%20By%20constructing%20and%20analyzing%20laboratory%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20M.%20tuberculosis%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20strains%20carrying%20these%20specific%20mutations%2C%20we%20found%20numerous%20changes%20in%20their%20transcriptional%20profiles%2C%20whereas%20we%20observed%20only%20a%20little%20impact%20of%20these%20mutations%20on%20the%20virulence%20of%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20M.%20tuberculosis%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20in%20a%20mouse%20infection%20model.%20Our%20study%20provides%20new%20insights%20into%20the%20transcriptional%20landscape%20of%20the%20selected%20MDR%20strains%2C%20although%20no%20direct%20connection%20to%20virulence%20could%20be%20established.%22%2C%22date%22%3A%222025-05-22%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1128%5C%2Fspectrum.03224-24%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fjournals.asm.org%5C%2Fdoi%5C%2F10.1128%5C%2Fspectrum.03224-24%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%222165-0497%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-05-23T07%3A24%3A06Z%22%7D%7D%2C%7B%22key%22%3A%223GKCD4HL%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Chauffour%20et%20al.%22%2C%22parsedDate%22%3A%222025-05-08%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BChauffour%2C%20A.%2C%20Cambau%2C%20E.%2C%20Pethe%2C%20K.%2C%20Veziris%2C%20N.%20and%20Aubry%2C%20A.%20%282025%29.%20%26lt%3Bb%26gt%3BUnprecedented%20in%20vivo%20activity%20of%20telacebec%20against%20Mycobacterium%20leprae%26lt%3B%5C%2Fb%26gt%3B%20Ed.%20Steinmann%2C%20P.%20PLoS%20Negl%20Trop%20Dis%20%26lt%3Bi%26gt%3B19%26lt%3B%5C%2Fi%26gt%3B%2C%20e0013076%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pntd.0013076%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pntd.0013076%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Unprecedented%20in%20vivo%20activity%20of%20telacebec%20against%20Mycobacterium%20leprae%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aur%5Cu00e9lie%22%2C%22lastName%22%3A%22Chauffour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%22%2C%22lastName%22%3A%22Pethe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Steinmann%22%7D%5D%2C%22abstractNote%22%3A%22Background%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20New%20drugs%20targeting%20the%20electron%20transport%20chain%20%28ETC%29%20seem%20to%20be%20a%20promising%20advance%20in%20leprosy%20treatment.%20In%20this%20study%2C%20we%20evaluated%20the%20bactericidal%20activity%20of%20telacebec%20%28TCB%29%2C%20a%20phase%202%20drug%20candidate%20for%20tuberculosis%2C%20alongside%20known%20ETC-targeting%20antibiotics%2C%20bedaquiline%20%28BDQ%29%20and%20clofazimine%20%28CFZ%29%2C%20as%20monotherapy%20or%20in%20combination.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Methodology%5C%2F%20Principal%20Findings%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20We%20used%20the%20reference%20leprosy%20proportional%20bactericidal%20mouse%20footpad%20model.%20Four%20hundred%20and%20ten%20mice%20were%20inoculated%20in%20the%20footpads%20with%205x10%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%204%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20to%205x10%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%200%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20bacilli%20of%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20M.%20leprae%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20strain%20THAI53%20for%20the%20untreated%20control%20group%20and%20groups%20treated%20with%20drug-monotherapies%2C%20and%20with%205x10%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%204%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20to%205x10%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%201%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20for%20groups%20treated%20with%20drug-combinations.%20Mice%20were%20randomly%20allocated%20into%20the%20following%20groups%3A%202%20control%20groups%20%28untreated%20or%20standard%20multi%20drug%20therapy%20%28MDT%29%2C%20rifampin%2C%20dapsone%20and%20clofazimine%20with%20dosing%20equipotent%20to%20human%20dosing%29%20and%207%20test%20groups%20%28TCB%2010mg%5C%2Fkg%2C%20bedaquiline%2025mg%5C%2Fkg%20%28BDQ%29%2C%20clofazimine%2020mg%5C%2Fkg%20%28CFZ%29%2C%20CFZ%5Cu2009%2B%5Cu2009BDQ%2C%20TCB%5Cu2009%2B%5Cu2009BDQ%2C%20TCB%5Cu2009%2B%5Cu2009CFZ%2C%20TCB%5Cu2009%2B%5Cu2009CFZ%5Cu2009%2B%5Cu2009BDQ%29.%20Mice%20in%20the%20test%20groups%20received%20either%20one%20month%20treatment%20%28MDT%29%20or%20a%20single%20dose%20of%20the%20drugs%20%28TCB%2C%20RIF%2C%20BDQ%2C%20CFZ%29.%20Twelve%20months%20later%2C%20mice%20were%20sacrificed%20to%20enumerate%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20M.%20leprae%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20bacilli%20in%20the%20footpad.%20All%20the%20footpads%20became%20negative%20in%20the%20MDT%2C%20TCB%20and%20combination%20groups%20except%20in%20the%20TCB%5Cu2009%2B%5Cu2009CFZ%20group%20where%202%20mice%20remained%20positive%20in%20the%205x10%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%204%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20inoculum.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Conclusion%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20We%20demonstrated%20that%20monotherapy%20of%20TCB%20exhibited%20bactericidal%20activity%20against%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20M.%20leprae%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20comparable%20to%20that%20of%20MDT%20and%20that%20all%20combination%20therapies%20were%20as%20effective%20as%20MDT%2C%20except%20the%20combination%20TCB%5Cu2009%2B%5Cu2009CFZ%2C%20possibly%20due%20to%20an%20antagonism%20between%20these%20two%20drugs.%22%2C%22date%22%3A%222025-5-8%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pntd.0013076%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdx.plos.org%5C%2F10.1371%5C%2Fjournal.pntd.0013076%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221935-2735%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-05-09T12%3A31%3A57Z%22%7D%7D%2C%7B%22key%22%3A%22K52S8828%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Fomba%20et%20al.%22%2C%22parsedDate%22%3A%222025-06-04%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BFomba%2C%20A.%2C%20Haidara%2C%20F.%20C.%2C%20Kodio%2C%20M.%2C%20Arama%2C%20C.%2C%20Cambau%2C%20E.%2C%20Chauffour%2C%20A.%2C%20Veziris%2C%20N.%2C%20Broeckling%2C%20B.%20E.%2C%20Warren%2C%20A.%20K.%2C%20Cauchoix%2C%20B.%2C%20Alca%26%23xEF%3Bs%2C%20A.%2C%20Marsollier%2C%20L.%2C%20Ass%26%23xE9%3B%2C%20H.%2C%20Jackson%2C%20M.%2C%20Sow%2C%20S.%20O.%2C%20Faye%2C%20O.%2C%20Jarlier%2C%20V.%2C%20Cole%2C%20S.%20T.%2C%20Avanzi%2C%20C.%2C%20Aubry%2C%20A.%20and%20Johnson%2C%20R.%20C.%20%282025%29.%20%26lt%3Bb%26gt%3BBedaquiline%20Activity%20against%20Leprosy%26lt%3B%5C%2Fb%26gt%3B.%20New%20England%20Journal%20of%20Medicine%20%26lt%3Bi%26gt%3B392%26lt%3B%5C%2Fi%26gt%3B%2C%202174%26%23x2013%3B2176%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1056%5C%2FNEJMc2412487%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1056%5C%2FNEJMc2412487%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Bedaquiline%20Activity%20against%20Leprosy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abdoulaye%22%2C%22lastName%22%3A%22Fomba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fadima%20C.%22%2C%22lastName%22%3A%22Haidara%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mamoudou%22%2C%22lastName%22%3A%22Kodio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22Arama%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aur%5Cu00e9lie%22%2C%22lastName%22%3A%22Chauffour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bettina%20E.%22%2C%22lastName%22%3A%22Broeckling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alaine%20K.%22%2C%22lastName%22%3A%22Warren%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bertrand%22%2C%22lastName%22%3A%22Cauchoix%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandre%22%2C%22lastName%22%3A%22Alca%5Cu00efs%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurent%22%2C%22lastName%22%3A%22Marsollier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Henri%22%2C%22lastName%22%3A%22Ass%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary%22%2C%22lastName%22%3A%22Jackson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samba%20Ousmane%22%2C%22lastName%22%3A%22Sow%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ousmane%22%2C%22lastName%22%3A%22Faye%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stewart%20T.%22%2C%22lastName%22%3A%22Cole%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charlotte%22%2C%22lastName%22%3A%22Avanzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roch%20C.%22%2C%22lastName%22%3A%22Johnson%22%7D%5D%2C%22abstractNote%22%3A%22In%20this%20report%2C%2030%20patients%20in%20Mali%20with%20untreated%20multibacillary%20leprosy%20were%20treated%20with%20bedaquiline%20for%208%20weeks%2C%20followed%20by%20standard%20multidrug%20therapy.%20Cultures%20were%20cleared%20in%20all%20the%20patients%20with%20bedaquiline%20therapy.%22%2C%22date%22%3A%222025-06-04%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1056%5C%2FNEJMc2412487%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nejm.org%5C%2Fdoi%5C%2Ffull%5C%2F10.1056%5C%2FNEJMc2412487%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220028-4793%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-06-07T08%3A23%3A39Z%22%7D%7D%2C%7B%22key%22%3A%22UHTR8XPZ%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Fouchet%20et%20al.%22%2C%22parsedDate%22%3A%222025-12-17%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BFouchet%2C%20T.%2C%20Nait%20Chabane%2C%20M.%2C%20Allam%2C%20C.%2C%20Awad%2C%20Z.%2C%20Mougari%2C%20F.%2C%20Hartmann%2C%20A.%2C%20Rochelet%2C%20M.%20and%20Cambau%2C%20E.%20%282025%29.%20%26lt%3Bb%26gt%3BClinical%20evaluation%20of%20the%20diagnostic%20performances%20and%20treatment%20monitoring%20of%20the%20new%20PATHFAST%20TB%20LAM%20Ag%20assay%20in%20sputum%20specimens%20of%20patients%20with%20tuberculosis%20or%20with%20nontuberculous%20mycobacteria%20pulmonary%20disease%26lt%3B%5C%2Fb%26gt%3B%20Ed.%20Miller%2C%20M.%20B.%20J%20Clin%20Microbiol%20%26lt%3Bi%26gt%3B63%26lt%3B%5C%2Fi%26gt%3B%2C%20e01269-25%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2Fjcm.01269-25%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2Fjcm.01269-25%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Clinical%20evaluation%20of%20the%20diagnostic%20performances%20and%20treatment%20monitoring%20of%20the%20new%20PATHFAST%20TB%20LAM%20Ag%20assay%20in%20sputum%20specimens%20of%20patients%20with%20tuberculosis%20or%20with%20nontuberculous%20mycobacteria%20pulmonary%20disease%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Theo%22%2C%22lastName%22%3A%22Fouchet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melissa%22%2C%22lastName%22%3A%22Nait%20Chabane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Camille%22%2C%22lastName%22%3A%22Allam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zeina%22%2C%22lastName%22%3A%22Awad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fa%5Cu00efza%22%2C%22lastName%22%3A%22Mougari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alain%22%2C%22lastName%22%3A%22Hartmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Murielle%22%2C%22lastName%22%3A%22Rochelet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22Melissa%20B.%22%2C%22lastName%22%3A%22Miller%22%7D%5D%2C%22abstractNote%22%3A%22ABSTRACT%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20Diagnosing%20pulmonary%20tuberculosis%20%28TB%29%20and%20monitoring%20treatment%20remain%20challenging.%20New%20tools%20such%20as%20the%20PATHFAST%20TB%20LAM%20assay%20%28PHC%20Corporation%2C%20formerly%20LSI%20Medience%20Corporation%2C%20Tokyo%2C%20Japan%3B%20distributed%20by%20BioSynex%2C%20France%3B%20PF-LAM%29%20may%20complement%20microscopy%2C%20culture%2C%20and%20NAAT.%20PF-LAM%20is%20an%20immunoassay%20quantifying%20lipoarabinomannan%20%28LAM%29%2C%20a%20mycobacterial%20cell%20wall%20component%2C%20in%20sputum%20within%201%20hour%20using%20an%20automated%20chemiluminescent%20reader.%20Diagnostic%20performance%20was%20first%20assessed%20on%20100%20sputum%20samples%3A%2040%20culture-positive%20for%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20Mycobacterium%20tuberculosis%20complex%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%28MTBC%29%2C%2040%20culture-positive%20for%20nontuberculous%20mycobacteria%20%28NTM%29%2C%20and%2020%20culture-negative%20for%20both.%20We%20then%20tested%2061%20longitudinal%20sputum%20samples%20from%2019%20pulmonary%20TB%20patients%20under%20treatment.%20Four%20additional%20samples%20from%20one%20patient%20with%20NTM%20pulmonary%20disease%20%28NTM-PD%29%20were%20also%20tested.%20PF-LAM%20showed%2075%25%20sensitivity%20for%20MTBC%20detection%2C%20with%20a%20strong%20correlation%20between%20LAM%20concentration%20and%20culture%20time-to-positivity%20%28Spearman%20%5Cu03c1%20%3D%200.915%2C%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20P%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%26lt%3B%200.0001%29.%20Specificity%20was%2095%25%20on%20culture-negative%20specimens.%20The%20test%20was%20also%20positive%20for%2026%5C%2F40%20%2865%25%29%20NTM-culture-positive%20samples.%20Notably%2C%2019%20of%20these%2026%20samples%20were%20obtained%20from%20NTM-PD%20patients%2C%20yielding%2073%25%20sensitivity%20for%20NTM-PD%20detection.%20The%20assay%5Cu2019s%20potential%20for%20treatment%20monitoring%20was%20demonstrated%20by%20significant%20negative%20correlations%20between%20LAM%20concentration%20and%20%28a%29%20treatment%20duration%20%28%5Cu03c1%3D%5Cu20130.434%2C%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20P%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%3D%200.0012%29%20and%20%28b%29%20time%20to%20positive%20culture%20%28%5Cu03c1%3D%5Cu20130.665%2C%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20P%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%26lt%3B%200.0001%29.%20PF-LAM%20is%20a%20rapid%20and%20easy-to-use%20test%20for%20diagnosing%20pulmonary%20TB.%20While%20NTM%20cross-reactivity%20reduces%20specificity%2C%20it%20may%20provide%20diagnostic%20value%20for%20NTM-PD.%20Results%20on%20monitoring%20TB%20treatment%20are%20promising%20as%20no%20test%20is%20currently%20available%20for%20this%20indication.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20IMPORTANCE%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Effective%20monitoring%20of%20the%20treatment%20response%20is%20essential%20for%20successful%20tuberculosis%20%28TB%29%20management%20as%20prolonged%20therapies%20require%20accurate%20evaluation%20to%20prevent%20relapse%2C%20treatment%20failure%2C%20or%20drug%20resistance.%20This%20study%20highlights%20the%20diagnostic%20and%20treatment-monitoring%20potential%20of%20the%20PATHFAST%20TB%20LAM%20Ag%20assay%2C%20which%20quantifies%20lipoarabinomannan%20%28LAM%29%20concentrations%20in%20sputum%20samples%20and%20correlates%20with%20bacterial%20load.%20For%20the%20first%20time%2C%20we%20also%20demonstrate%20the%20assay%5Cu2019s%20applicability%20for%20detecting%20and%20monitoring%20nontuberculous%20mycobacterial%20%28NTM%29%20pulmonary%20diseases%2C%20which%20are%20increasingly%20prevalent%20in%20industrialized%20countries.%20The%20semi-automated%2C%20rapid%20format%20%28%26lt%3B17%20minutes%29%20of%20the%20PATHFAST%20TB%20LAM%20Ag%20assay%20provides%20a%20simple%20and%20reliable%20approach%20for%20assessing%20bacillary%20load%20during%20treatment%2C%20representing%20a%20promising%20tool%20for%20improving%20patient%20management%20and%20diagnostic%20efficiency%20in%20both%20TB%20and%20NTM-PD.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%2C%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20Effective%20monitoring%20of%20the%20treatment%20response%20is%20essential%20for%20successful%20tuberculosis%20%28TB%29%20management%20as%20prolonged%20therapies%20require%20accurate%20evaluation%20to%20prevent%20relapse%2C%20treatment%20failure%2C%20or%20drug%20resistance.%20This%20study%20highlights%20the%20diagnostic%20and%20treatment-monitoring%20potential%20of%20the%20PATHFAST%20TB%20LAM%20Ag%20assay%2C%20which%20quantifies%20lipoarabinomannan%20%28LAM%29%20concentrations%20in%20sputum%20samples%20and%20correlates%20with%20bacterial%20load.%20For%20the%20first%20time%2C%20we%20also%20demonstrate%20the%20assay%5Cu2019s%20applicability%20for%20detecting%20and%20monitoring%20nontuberculous%20mycobacterial%20%28NTM%29%20pulmonary%20diseases%2C%20which%20are%20increasingly%20prevalent%20in%20industrialized%20countries.%20The%20semi-automated%2C%20rapid%20format%20%28%26lt%3B17%20minutes%29%20of%20the%20PATHFAST%20TB%20LAM%20Ag%20assay%20provides%20a%20simple%20and%20reliable%20approach%20for%20assessing%20bacillary%20load%20during%20treatment%2C%20representing%20a%20promising%20tool%20for%20improving%20patient%20management%20and%20diagnostic%20efficiency%20in%20both%20TB%20and%20NTM-PD.%22%2C%22date%22%3A%222025-12-17%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1128%5C%2Fjcm.01269-25%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fjournals.asm.org%5C%2Fdoi%5C%2F10.1128%5C%2Fjcm.01269-25%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220095-1137%2C%201098-660X%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-12-26T10%3A41%3A49Z%22%7D%7D%2C%7B%22key%22%3A%22BLP8X3WW%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gerussi%20et%20al.%22%2C%22parsedDate%22%3A%222025%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGerussi%2C%20V.%2C%20Petersen%2C%20T.%2C%20Bonnet%2C%20I.%2C%20Aubry%2C%20A.%2C%20Bachir%2C%20M.%2C%20Gyde%2C%20E.%2C%20Morel%2C%20F.%2C%20Poignon%2C%20C.%2C%20Rached%2C%20B.%2C%20Pourcher%2C%20V.%2C%20Rioux%2C%20C.%2C%20Vallois%2C%20D.%2C%20Veziris%2C%20N.%2C%20Robert%2C%20J.%20and%20Guglielmetti%2C%20L.%20%282025%29.%20%26lt%3Bb%26gt%3BEvaluation%20of%20High-Dose%20Isoniazid%20in%20Multidrug-Resistant%20Tuberculosis%20Treatment%26lt%3B%5C%2Fb%26gt%3B.%20Emerg%20Infect%20Dis%20%26lt%3Bi%26gt%3B31%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3201%5C%2Feid3103.241473%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3201%5C%2Feid3103.241473%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Evaluation%20of%20High-Dose%20Isoniazid%20in%20Multidrug-Resistant%20Tuberculosis%20Treatment%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valentina%22%2C%22lastName%22%3A%22Gerussi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tania%22%2C%22lastName%22%3A%22Petersen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabelle%22%2C%22lastName%22%3A%22Bonnet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marwa%22%2C%22lastName%22%3A%22Bachir%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Esther%22%2C%22lastName%22%3A%22Gyde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Morel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Corentin%22%2C%22lastName%22%3A%22Poignon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brigitte%22%2C%22lastName%22%3A%22Rached%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Val%5Cu00e9rie%22%2C%22lastName%22%3A%22Pourcher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christophe%22%2C%22lastName%22%3A%22Rioux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Doroth%5Cu00e9e%22%2C%22lastName%22%3A%22Vallois%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00e9r%5Cu00f4me%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2203%5C%2F2025%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.3201%5C%2Feid3103.241473%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwwwnc.cdc.gov%5C%2Feid%5C%2Farticle%5C%2F31%5C%2F3%5C%2F24-1473_article%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221080-6040%2C%201080-6059%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-03-04T14%3A01%3A41Z%22%7D%7D%2C%7B%22key%22%3A%222A6Z64ZV%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Goletti%20et%20al.%22%2C%22parsedDate%22%3A%222025%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGoletti%2C%20D.%2C%20Banaei%2C%20N.%2C%20Batra%2C%20R.%2C%20Berger%2C%20A.%20E.%2C%20Blazevic%2C%20A.%2C%20Botelho-Nevers%2C%20E.%2C%20Breen%2C%20R.%2C%20Bruiners%2C%20N.%2C%20Cambau%2C%20E.%2C%20Carbonnelle%2C%20E.%2C%20Daley%2C%20C.%20L.%2C%20Descotes-Genon%2C%20C.%2C%20Gennaro%2C%20F.%20D.%2C%20Doucet-Populaire%2C%20F.%2C%20Esmail%2C%20A.%2C%20Guzman%2C%20J.%20D.%20E.%2C%20Fontana%2C%20L.%2C%20Gennaro%2C%20M.%20L.%2C%20Handler%2C%20D.%2C%20Torres%2C%20R.%20M.%20H.%2C%20Hoft%2C%20D.%2C%20Ismail%2C%20N.%2C%20Isnard%2C%20M.%2C%20Kenny%2C%20J.%2C%20Lardizabal%2C%20A.%2C%20Lesage%2C%20F.%20X.%2C%20Lopes%2C%20A.%2C%20Vidal%2C%20W.%20L.%20L.%2C%20Contreras%2C%20R.%20M.%2C%20Manivet%2C%20P.%2C%20Marotte%2C%20H.%2C%20M%26%23xE9%3Bcha%26%23xEF%3B%2C%20F.%2C%20Medjahed-Artebasse%2C%20A.%2C%20Meldau%2C%20R.%2C%20M%26%23xE9%3Brieux%2C%20Y.%2C%20Morel%2C%20J.%2C%20Mougari%2C%20F.%2C%20Oelofse%2C%20S.%2C%20Palmieri%2C%20F.%2C%20Perrot%2C%20J.%20L.%2C%20Petruccioli%2C%20E.%2C%20Pride%2C%20D.%20T.%2C%20Tuaillon%2C%20E.%2C%20Upton%2C%20C.%2C%20Vanker%2C%20N.%20and%20Dheda%2C%20K.%20%282025%29.%20%26lt%3Bb%26gt%3BAccuracy%20of%20VIDAS%26%23xAE%3B%20TB-IGRA%20in%20TB%20patients%20and%20individuals%20with%20different%20thresholds%20of%20exposure%26lt%3B%5C%2Fb%26gt%3B.%20International%20Journal%20of%20Infectious%20Diseases%20108318%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ijid.2025.108318%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ijid.2025.108318%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Accuracy%20of%20VIDAS%5Cu00ae%20TB-IGRA%20in%20TB%20patients%20and%20individuals%20with%20different%20thresholds%20of%20exposure%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Delia%22%2C%22lastName%22%3A%22Goletti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Niaz%22%2C%22lastName%22%3A%22Banaei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rahul%22%2C%22lastName%22%3A%22Batra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%20Emmanuelle%22%2C%22lastName%22%3A%22Berger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Azra%22%2C%22lastName%22%3A%22Blazevic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elisabeth%22%2C%22lastName%22%3A%22Botelho-Nevers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ronan%22%2C%22lastName%22%3A%22Breen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natalie%22%2C%22lastName%22%3A%22Bruiners%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Etienne%22%2C%22lastName%22%3A%22Carbonnelle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20L.%22%2C%22lastName%22%3A%22Daley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%5Cu00e9cile%22%2C%22lastName%22%3A%22Descotes-Genon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francesco%20Di%22%2C%22lastName%22%3A%22Gennaro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Doucet-Populaire%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aliasgar%22%2C%22lastName%22%3A%22Esmail%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julia%20Dolores%20Estrada%22%2C%22lastName%22%3A%22Guzman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luc%22%2C%22lastName%22%3A%22Fontana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%20Laura%22%2C%22lastName%22%3A%22Gennaro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deborah%22%2C%22lastName%22%3A%22Handler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rosa%20Mar%5Cu00eda%20Herrera%22%2C%22lastName%22%3A%22Torres%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Hoft%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nahed%22%2C%22lastName%22%3A%22Ismail%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Margaux%22%2C%22lastName%22%3A%22Isnard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julia%22%2C%22lastName%22%3A%22Kenny%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alfred%22%2C%22lastName%22%3A%22Lardizabal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fran%5Cu00e7ois%20Xavier%22%2C%22lastName%22%3A%22Lesage%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amanda%22%2C%22lastName%22%3A%22Lopes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Williams%20Luciano%20L%5Cu00f3pez%22%2C%22lastName%22%3A%22Vidal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rene%20Machado%22%2C%22lastName%22%3A%22Contreras%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philippe%22%2C%22lastName%22%3A%22Manivet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hubert%22%2C%22lastName%22%3A%22Marotte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fr%5Cu00e9d%5Cu00e9ric%22%2C%22lastName%22%3A%22M%5Cu00e9cha%5Cu00ef%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amel%22%2C%22lastName%22%3A%22Medjahed-Artebasse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%22%2C%22lastName%22%3A%22Meldau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yves%22%2C%22lastName%22%3A%22M%5Cu00e9rieux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacques%22%2C%22lastName%22%3A%22Morel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faiza%22%2C%22lastName%22%3A%22Mougari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Suzette%22%2C%22lastName%22%3A%22Oelofse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabrizio%22%2C%22lastName%22%3A%22Palmieri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20Luc%22%2C%22lastName%22%3A%22Perrot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elisa%22%2C%22lastName%22%3A%22Petruccioli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20T.%22%2C%22lastName%22%3A%22Pride%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edouard%22%2C%22lastName%22%3A%22Tuaillon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caryn%22%2C%22lastName%22%3A%22Upton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naadira%22%2C%22lastName%22%3A%22Vanker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keertan%22%2C%22lastName%22%3A%22Dheda%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2212%5C%2F2025%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ijid.2025.108318%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS1201971225005351%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%2212019712%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-12-26T10%3A40%3A06Z%22%7D%7D%2C%7B%22key%22%3A%22SV4N7KNK%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Guglielmetti%20et%20al.%22%2C%22parsedDate%22%3A%222025-01-30%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGuglielmetti%2C%20L.%2C%20Khan%2C%20U.%2C%20Vel%26%23xE1%3Bsquez%2C%20G.%20E.%2C%20Gouillou%2C%20M.%2C%20Abubakirov%2C%20A.%2C%20Baudin%2C%20E.%2C%20Berikova%2C%20E.%2C%20Berry%2C%20C.%2C%20Bonnet%2C%20M.%2C%20Cellamare%2C%20M.%2C%20Chavan%2C%20V.%2C%20Cox%2C%20V.%2C%20Dakenova%2C%20Z.%2C%20De%20Jong%2C%20B.%20C.%2C%20Ferlazzo%2C%20G.%2C%20Karabayev%2C%20A.%2C%20Kirakosyan%2C%20O.%2C%20Kiria%2C%20N.%2C%20Kunda%2C%20M.%2C%20Lachenal%2C%20N.%2C%20Lecca%2C%20L.%2C%20McIlleron%2C%20H.%2C%20Motta%2C%20I.%2C%20Toscano%2C%20S.%20M.%2C%20Mushtaque%2C%20H.%2C%20Nahid%2C%20P.%2C%20Oyewusi%2C%20L.%2C%20Panda%2C%20S.%2C%20Patil%2C%20S.%2C%20Phillips%2C%20P.%20P.%20J.%2C%20Ruiz%2C%20J.%2C%20Salahuddin%2C%20N.%2C%20Garavito%2C%20E.%20S.%2C%20Seung%2C%20K.%20J.%2C%20Ticona%2C%20E.%2C%20Trippa%2C%20L.%2C%20Vasquez%2C%20D.%20E.%20V.%2C%20Wasserman%2C%20S.%2C%20Rich%2C%20M.%20L.%2C%20Varaine%2C%20F.%20and%20Mitnick%2C%20C.%20D.%20%282025%29.%20%26lt%3Bb%26gt%3BOral%20Regimens%20for%20Rifampin-Resistant%2C%20Fluoroquinolone-Susceptible%20Tuberculosis%26lt%3B%5C%2Fb%26gt%3B.%20N%20Engl%20J%20Med%20%26lt%3Bi%26gt%3B392%26lt%3B%5C%2Fi%26gt%3B%2C%20468%26%23x2013%3B482%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1056%5C%2FNEJMoa2400327%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1056%5C%2FNEJMoa2400327%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Oral%20Regimens%20for%20Rifampin-Resistant%2C%20Fluoroquinolone-Susceptible%20Tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Uzma%22%2C%22lastName%22%3A%22Khan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gustavo%20E.%22%2C%22lastName%22%3A%22Vel%5Cu00e1squez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maelenn%22%2C%22lastName%22%3A%22Gouillou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amanzhan%22%2C%22lastName%22%3A%22Abubakirov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elisabeth%22%2C%22lastName%22%3A%22Baudin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elmira%22%2C%22lastName%22%3A%22Berikova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22Berry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maryline%22%2C%22lastName%22%3A%22Bonnet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matteo%22%2C%22lastName%22%3A%22Cellamare%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vijay%22%2C%22lastName%22%3A%22Chavan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vivian%22%2C%22lastName%22%3A%22Cox%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhanna%22%2C%22lastName%22%3A%22Dakenova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bouke%20Catherine%22%2C%22lastName%22%3A%22De%20Jong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriella%22%2C%22lastName%22%3A%22Ferlazzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aydarkhan%22%2C%22lastName%22%3A%22Karabayev%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ohanna%22%2C%22lastName%22%3A%22Kirakosyan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nana%22%2C%22lastName%22%3A%22Kiria%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mikanda%22%2C%22lastName%22%3A%22Kunda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%22%2C%22lastName%22%3A%22Lachenal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leonid%22%2C%22lastName%22%3A%22Lecca%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helen%22%2C%22lastName%22%3A%22McIlleron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ilaria%22%2C%22lastName%22%3A%22Motta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sergio%20Mucching%22%2C%22lastName%22%3A%22Toscano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hebah%22%2C%22lastName%22%3A%22Mushtaque%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Payam%22%2C%22lastName%22%3A%22Nahid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lawrence%22%2C%22lastName%22%3A%22Oyewusi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samiran%22%2C%22lastName%22%3A%22Panda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandip%22%2C%22lastName%22%3A%22Patil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20P.%20J.%22%2C%22lastName%22%3A%22Phillips%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jimena%22%2C%22lastName%22%3A%22Ruiz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naseem%22%2C%22lastName%22%3A%22Salahuddin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Epifanio%20Sanchez%22%2C%22lastName%22%3A%22Garavito%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kwonjune%20J.%22%2C%22lastName%22%3A%22Seung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%22%2C%22lastName%22%3A%22Ticona%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Trippa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dante%20E.%20Vargas%22%2C%22lastName%22%3A%22Vasquez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sean%22%2C%22lastName%22%3A%22Wasserman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20L.%22%2C%22lastName%22%3A%22Rich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francis%22%2C%22lastName%22%3A%22Varaine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carole%20D.%22%2C%22lastName%22%3A%22Mitnick%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222025-01-30%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1056%5C%2FNEJMoa2400327%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.nejm.org%5C%2Fdoi%5C%2F10.1056%5C%2FNEJMoa2400327%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220028-4793%2C%201533-4406%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-02-13T10%3A18%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22XRN4SZWD%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Guglielmetti%20et%20al.%22%2C%22parsedDate%22%3A%222025%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGuglielmetti%2C%20L.%2C%20Panda%2C%20S.%2C%20Abubakirov%2C%20A.%2C%20Salahuddin%2C%20N.%2C%20Perrin%2C%20C.%20and%20Mitnick%2C%20C.%20D.%20%282025%29.%20%26lt%3Bb%26gt%3BEquitable%2C%20personalised%20medicine%20for%20tuberculosis%3A%20treating%20patients%2C%20not%20diseases%26lt%3B%5C%2Fb%26gt%3B.%20The%20Lancet%20Respiratory%20Medicine%20%26lt%3Bi%26gt%3B13%26lt%3B%5C%2Fi%26gt%3B%2C%20382%26%23x2013%3B385%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS2213-2600%2825%2900080-3%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS2213-2600%2825%2900080-3%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Equitable%2C%20personalised%20medicine%20for%20tuberculosis%3A%20treating%20patients%2C%20not%20diseases%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samiran%22%2C%22lastName%22%3A%22Panda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amanzhan%22%2C%22lastName%22%3A%22Abubakirov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naseem%22%2C%22lastName%22%3A%22Salahuddin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christophe%22%2C%22lastName%22%3A%22Perrin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carole%20D%22%2C%22lastName%22%3A%22Mitnick%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2205%5C%2F2025%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2FS2213-2600%2825%2900080-3%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS2213260025000803%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%2222132600%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-05-09T13%3A32%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22G5G79UG2%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Guglielmetti%20et%20al.%22%2C%22parsedDate%22%3A%222025-07-16%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGuglielmetti%2C%20L.%2C%20Khan%2C%20U.%2C%20Vel%26%23xE1%3Bsquez%2C%20G.%20E.%2C%20Gouillou%2C%20M.%2C%20Ali%2C%20M.%20H.%2C%20Amjad%2C%20S.%2C%20Kamal%2C%20F.%2C%20Abubakirov%2C%20A.%2C%20Ardizzoni%2C%20E.%2C%20Baudin%2C%20E.%2C%20Bektassov%2C%20S.%2C%20Berry%2C%20C.%2C%20Bonnet%2C%20M.%2C%20Chavan%2C%20V.%2C%20Coutisson%2C%20S.%2C%20Dakenova%2C%20Z.%2C%20de%20Jong%2C%20B.%20C.%2C%20Dinh%2C%20L.%20V.%2C%20Ferlazzo%2C%20G.%2C%20Kirakosyan%2C%20O.%2C%20Lachenal%2C%20N.%2C%20Lecca%2C%20L.%2C%20McIlleron%2C%20H.%2C%20Mikanda%2C%20K.%20K.%2C%20Mucching-Toscano%2C%20S.%2C%20Mulders%2C%20W.%2C%20Mushtaque%2C%20H.%2C%20Nahid%2C%20P.%2C%20Nguyen%2C%20D.%20V.%2C%20Nguyen%2C%20N.%20V.%2C%20Oyewusi%2C%20L.%2C%20Motta%2C%20I.%2C%20Panda%2C%20S.%2C%20Patil%2C%20Sandip%2C%20Pham%2C%20T.%20H.%2C%20Phan%2C%20D.%20T.%2C%20Phan%2C%20H.%20T.%20T.%2C%20Phillips%2C%20P.%20P.%20J.%2C%20Ruiz%2C%20J.%2C%20Rupasinghe%2C%20Praharshinie%2C%20Salahuddin%2C%20N.%2C%20Sanchez-Garavito%2C%20E.%2C%20Seung%2C%20K.%20J.%2C%20Asfaw%2C%20M.%20T.%2C%20Vargas%20Vasquez%2C%20D.%2C%20Rich%2C%20M.%20L.%2C%20Varaine%2C%20F.%2C%20Mitnick%2C%20C.%20D.%2C%20Arora%2C%20G.%2C%20Ashara%2C%20V.%2C%20Bhattacharjee%2C%20S.%2C%20Borkar%2C%20R.%2C%20Chincholikar%2C%20N.%2C%20Choudhary%2C%20N.%2C%20Davuluri%2C%20P.%2C%20Desai%2C%20N.%2C%20Dipika%2C%20Dhongade%2C%20S.%2C%20Dulani%2C%20D.%2C%20Ghule%2C%20S.%2C%20Hirani%2C%20N.%2C%20Hurali%2C%20P.%2C%20Irani%2C%20R.%2C%20Jadhav%2C%20K.%2C%20Jadhav%2C%20P.%2C%20Jadhav%2C%20R.%2C%20Joseph%2C%20N.%2C%20Joshi%2C%20A.%2C%20Joshi%2C%20P.%2C%20K%2C%20A.%2C%20K%2C%20S.%2C%20Kamble%2C%20M.%2C%20Kate%2C%20R.%2C%20Keer%2C%20T.%2C%20S%20Kenche%2C%20M.%2C%20Khandare%2C%20H.%2C%20Koli%2C%20P.%2C%20Kulkarni%2C%20A.%2C%20Patra%2C%20S.%20K.%2C%20Kuwar%2C%20A.%2C%20Lande%2C%20P.%2C%20Mane%2C%20N.%2C%20Masalge%2C%20P.%2C%20Mishra%2C%20P.%2C%20Mitkari%2C%20R.%2C%20More%2C%20A.%2C%20Munot%2C%20P.%2C%20Murgesh%2C%20R.%2C%20Muthe%2C%20S.%2C%20Nakashe%2C%20N.%2C%20Natarajan%2C%20D.%2C%20Paril%2C%20S.%2C%20Patil%2C%20Supriya%2C%20Patil%2C%20V.%2C%20Patwardhan%2C%20V.%2C%20Posture%2C%20V.%2C%20Pradeshi%2C%20A.%2C%20Prasad%2C%20V.%2C%20Pundir%2C%20B.%2C%20Rajendran%2C%20S.%2C%20Randhit%2C%20Y.%2C%20Rekart%2C%20M.%2C%20Samant%2C%20P.%2C%20Shaikh%2C%20H.%2C%20Sharma%2C%20A.%2C%20Sharma%2C%20N.%2C%20Sharma%2C%20S.%2C%20Shinde%2C%20N.%2C%20Shinde%2C%20S.%2C%20Shingare%2C%20G.%2C%20Shulka%2C%20A.%2C%20Shriwas%2C%20A.%2C%20Sonawane%2C%20L.%2C%20Sudhindra%2C%20U.%2C%20Suryavanshi%2C%20D.%2C%20Thakare%2C%20A.%2C%20Udare%2C%20D.%2C%20Vaidya%2C%20G.%2C%20Wagh%2C%20R.%2C%20Isenova%2C%20L.%2C%20Konigratbayeva%2C%20G.%2C%20Nurtayeva%2C%20G.%2C%20Zekeshov%2C%20N.%2C%20Chenu%2C%20R.%2C%20Garba%2C%20S.%2C%20Tozzi%2C%20D.%2C%20Yuya-Septoh%2C%20F.-J.%2C%20Thi%20Tuyet%20Mai%2C%20B.%2C%20Thi%20Hai%2C%20D.%2C%20Thi%20Thuy%2C%20D.%2C%20Thi%20Oanh%2C%20L.%2C%20Do%2C%20B.%20T.%2C%20Nguyen%2C%20D.%20T.%2C%20Nguyen%2C%20P.%20H.%2C%20Nguyen%2C%20T.%20M.%20A.%2C%20Nguyen%2C%20Thi%20Thuy%20Hanh%2C%20Nguyen%2C%20T.%20K.%20N.%2C%20Nguyen%2C%20T.%20N.%2C%20Nguyen%2C%20V.%20K.%2C%20Nog%2C%20N.%2C%20Pham%2C%20T.%20N.%2C%20Pham%2C%20T.%20L.%2C%20Pham%2C%20T.%20A.%2C%20Phung%2C%20T.%20B.%2C%20Tran%2C%20B.%20T.%2C%20Trinh%2C%20M.%20T.%2C%20Chang%2C%20E.%2C%20Coit%2C%20J.%2C%20Do%2C%20J.-M.%2C%20LaHood%2C%20A.%2C%20O%26%23x2019%3BBrien%2C%20K.%2C%20Okunbor%2C%20E.%2C%20Osso%2C%20E.%2C%20Ch%26%23xE1%3Bvez%2C%20V.%2C%20Larco%2C%20P.%2C%20Mendoza%2C%20D.%2C%20Robles%2C%20C.%2C%20Rojas%2C%20A.%2C%20Salazar%2C%20J.%2C%20Santos%2C%20G.%2C%20Sosa%2C%20J.%2C%20Ticona%2C%20C.%2C%20Carranza%2C%20S.%2C%20Delgado%2C%20D.%2C%20Galarza%2C%20C.%2C%20Murga%2C%20G.%2C%20Ramos%2C%20E.%2C%20Cantaro%2C%20K.%2C%20Huerta%2C%20A.%2C%20Maldonado%2C%20J.%2C%20Nu%26%23xF1%3Bez%2C%20R.%2C%20Panduro%2C%20K.%2C%20Rafael%2C%20R.%2C%20Abdul%2C%20A.%2C%20Abedin%2C%20S.%2C%20Afreen%2C%20E.%2C%20Ahmed%2C%20Sohail%2C%20Ahmed%2C%20U.%2C%20Ali%20Shah%2C%20J.%2C%20Ashraf%2C%20A.%2C%20Aslam%2C%20F.%2C%20Bashir%2C%20Z.%2C%20Fayyaz%2C%20S.%2C%20Hafeez%2C%20K.%2C%20Hamid%2C%20M.%2C%20Hassan%2C%20B.%2C%20Hussain%2C%20M.%2C%20Irfan%2C%20M.%2C%20Omar%2C%20M.%2C%20Parveen%2C%20S.%2C%20Sunail%2C%20S.%2C%20Farooq%2C%20M.%2C%20Mazhar%2C%20B.%2C%20Munir%2C%20S.%2C%20Sonia%2C%20N.%2C%20Yaseen%2C%20M.%2C%20Zubair%2C%20M.%2C%20Zehra%2C%20F.%2C%20Zulfiqar%2C%20I.%2C%20Abbasi%2C%20T.%2C%20Akbar%20Abro%2C%20G.%2C%20Ahmed%2C%20M.%2C%20Ahmed%2C%20N.%2C%20Hammad%20Ali%2C%20M.%2C%20Ali%2C%20N.%2C%20Danish%2C%20R.%2C%20Farhat%2C%20A.%2C%20Gill%2C%20S.%2C%20Hafeez%2C%20M.%2C%20Hussain%2C%20G.%2C%20Inayat%2C%20H.%2C%20Johnson%2C%20S.%2C%20Kamal%2C%20F.%2C%20Kamran%2C%20A.%2C%20Kumar%2C%20Sanjeet%2C%20Maheshwari%2C%20M.%2C%20Mamsa%2C%20S.%2C%20Massey%2C%20S.%2C%20Mehmood%2C%20A.%2C%20Memon%2C%20A.%2C%20Ali%20Mirani%2C%20A.%2C%20Naz%2C%20S.%2C%20Rafique%20Qureshi%2C%20T.%2C%20Roop%20Moazzam%20Sheikh%2C%20Y.%2C%20Rafi%20Siddiqui%2C%20M.%2C%20Singh%2C%20B.%2C%20Soomro%2C%20M.%2C%20Ardizzoni%2C%20E.%2C%20Rigouts%2C%20L.%2C%20Rupasinghe%2C%20Praha%2C%20Aftab%2C%20A.%2C%20Ahmed%2C%20Saman%2C%20Adnan%20Alamgir%2C%20M.%2C%20Ali%2C%20Ayaz%2C%20Ali%2C%20Azhar%2C%20Ahmed%20Ali%2C%20S.%2C%20Ali%2C%20S.%2C%20Altaf%2C%20S.%2C%20Amjad%2C%20S.%2C%20Sahiba%20Arshad%2C%20M.%2C%20Ausim%2C%20S.%2C%20Basit%2C%20A.%2C%20Ezik%2C%20H.%2C%20Hussain%2C%20H.%2C%20Hyder%2C%20S.%2C%20Inayat%2C%20S.%2C%20Janmohammed%2C%20A.%2C%20Jaseem%2C%20K.%2C%20Jawed%2C%20A.%2C%20Maniar%2C%20L.%2C%20Kumar%2C%20P.%2C%20Kumar%2C%20Susheel%2C%20Latif%2C%20R.%2C%20Liaqat%2C%20S.%2C%20Ammar%20Nasser%2C%20M.%2C%20Shakeel%2C%20M.%2C%20Shaikh%2C%20S.%2C%20Siddiqui%2C%20A.%2C%20Singh%2C%20J.%2C%20Sivan%2C%20K.%2C%20Taimoor%2C%20M.%2C%20Zia%2C%20N.%2C%20Li%2C%20I.%2C%20Otepbergenova%2C%20M.%2C%20Dinh%2C%20T.%20H.%2C%20Do%2C%20Thi%20Thu%2C%20Do%2C%20Thu%20Thuong%2C%20Le%2C%20T.%20N.%2C%20Nguyen%2C%20K.%20C.%2C%20Nguyen%2C%20T.%20T.%2C%20Nguyen%2C%20V.%20H.%2C%20Abildayeva%2C%20G.%2C%20Maryash%2C%20O.%2C%20Telegina%2C%20E.%2C%20Tursynbekova%2C%20L.%2C%20Amanzholova%2C%20Z.%2C%20Bektassova%2C%20P.%2C%20Belgozhanova%2C%20A.%2C%20Birimkulova%2C%20N.%2C%20Dyusebayeva%2C%20N.%2C%20Erkut%2C%20N.%2C%20Gusmanov%2C%20A.%2C%20Kassenova%2C%20B.%2C%20Kassym%2C%20A.%2C%20Khazhidinov%2C%20K.%2C%20Lee%2C%20T.%2C%20Magzumova%2C%20A.%2C%20Mussabayeva%2C%20M.%2C%20Omarova%2C%20G.%2C%20Ryapolova%2C%20N.%2C%20Sagyndykova%2C%20L.%2C%20Serekbay%2C%20A.%2C%20Stambekova%2C%20A.%2C%20Tanatarova%2C%20G.%2C%20Uaisov%2C%20Z.%2C%20Zhantuarova%2C%20Z.%2C%20Zhumakairova%2C%20G.%2C%20Arlyapova%2C%20N.%2C%20Bogus%2C%20J.%2C%20Cain%2C%20M.%2C%20Carmona%2C%20M.%2C%20Flanagan%2C%20C.%2C%20McAnaw%2C%20S.%2C%20Scharff%2C%20A.%2C%20Soni%2C%20S.%2C%20Striplin%2C%20M.%2C%20Abebe%2C%20S.%2C%20Alakaye%2C%20J.%2C%20Bulane%2C%20A.%2C%20Custodio%2C%20M.%2C%20Hajison%2C%20P.%2C%20Hetsa%2C%20M.%2C%20Holtzman%2C%20D.%2C%20Khesa%2C%20M.%2C%20Lethola%2C%20M.%2C%20Lebitsa%2C%20T.%2C%20Mahamo%2C%20M.%2C%20Makaka%2C%20J.%2C%20Matoko%2C%20M.%2C%20Mpinda%2C%20S.%2C%20Mohoang%2C%20P.%2C%20Monyaesa%2C%20D.%2C%20Nkundayirazo%2C%20P.%2C%20Ntsane%20Sesomo%20Mohale%2C%20M.%2C%20Ntsibane%2C%20S.%2C%20Phate%2C%20S.%2C%20Radebe%20%28Retsepile%20Tlali%29%2C%20M.%2C%20Rakhetsi%2C%20M.%2C%20Ranoosi%2C%20T.%2C%20Tamirat%2C%20M.%2C%20Thokoana%2C%20M.%2C%20Alegre%2C%20E.%2C%20Aguilar%2C%20C.%2C%20Armuto%2C%20L.%2C%20Barreda%2C%20N.%2C%20Barreto%2C%20M.%2C%20Cabrera%2C%20S.%2C%20Calderon%2C%20R.%2C%20Castro%2C%20M.%2C%20Chavez%2C%20J.%2C%20Chavez%2C%20L.%2C%20Cheje%2C%20H.%2C%20Cori%2C%20L.%2C%20D%26%23xE1%3Bvalos%2C%20D.%2C%20de%20la%20Gala%2C%20S.%2C%20Delgadillo%2C%20K.%2C%20Diaz%2C%20H.%2C%20Flores%2C%20X.%2C%20Galarza%2C%20J.%2C%20Garc%26%23xED%3Ba%2C%20D.%2C%20Garcia%2C%20F.%2C%20Gaspar%2C%20M.%2C%20Godos%2C%20R.%2C%20Gomez%2C%20P.%2C%20Gonzales%2C%20L.%2C%20Guerrero%2C%20L.%2C%20Inga%2C%20S.%2C%20Jasaycucho%2C%20J.%2C%20Martel%2C%20B.%2C%20Pro%20Martinez%2C%20A.%2C%20Molina%2C%20R.%2C%20Mugruza%2C%20R.%2C%20Mundaca%2C%20H.%2C%20Nuahan%2C%20M.%2C%20Ore%2C%20K.%2C%20Panduro%2C%20L.%2C%20Pe%26%23xF1%3Ba%2C%20O.%2C%20Perea%2C%20S.%2C%20Pinedo%2C%20C.%2C%20Ponce%2C%20Y.%2C%20Quinte%2C%20C.%2C%20Qui%26%23xF1%3Bones%2C%20M.%2C%20Ramos%2C%20A.%2C%20Ramirez%2C%20E.%2C%20Reynoso%2C%20R.%2C%20Reyes%2C%20C.%2C%20Reyes%2C%20J.%2C%20Riccio%2C%20V.%2C%20Robles%2C%20B.%2C%20Rojas%2C%20K.%2C%20Sanabria%2C%20O.%2C%20Saravia%2C%20M.%2C%20Saravia%2C%20S.%2C%20Senador%2C%20L.%2C%20Soberon%2C%20J.%2C%20Soncco%2C%20E.%2C%20Soto%2C%20M.%2C%20Suarez%2C%20C.%2C%20Suarez%2C%20M.%2C%20Suarez%2C%20V.%2C%20Torpoco%2C%20E.%2C%20Torres%2C%20O.%2C%20Torrez%2C%20C.%2C%20Tunque%2C%20G.%2C%20Ugarte%2C%20A.%2C%20Vaderrama%2C%20G.%2C%20Valdivia%2C%20W.%2C%20Valdivia%2C%20Y.%2C%20Valverde%2C%20I.%2C%20Vargas%2C%20C.%2C%20Vargas%2C%20J.%2C%20Vasquez%2C%20E.%2C%20Veliz%2C%20J.%2C%20Villa%2C%20D.%2C%20Villafuerte%2C%20S.%2C%20Villar%2C%20G.%2C%20Villegas%2C%20S.%2C%20Wong%2C%20M.%2C%20Yataco%2C%20R.%2C%20Pham%2C%20H.%2C%20Truong%2C%20H.%2C%20Nguyen%2C%20H.%2C%20Huy%2C%20V.%2C%20Nguyen%2C%20V.%20S.%2C%20Nguyen%2C%20T.%20M.%20K.%2C%20Minh%2C%20T.%2C%20Bui%2C%20D.%20T.%20T.%2C%20Truong%2C%20V.%20V.%2C%20Nguyen%2C%20Thi%20Thu%20Ha%2C%20Coutisson%2C%20S.%2C%20Atger%2C%20M.%2C%20Nadia%20Baya%2C%20S.%2C%20Bekhiet%2C%20M.%2C%20Boissi%26%23xE8%3Bre%2C%20V.%2C%20Caboclo%2C%20R.%2C%20Chaudhry%2C%20M.%2C%20Cloez%2C%20S.%2C%20Collin%2C%20S.%2C%20Delifer%2C%20C.%2C%20Demaisons%2C%20S.%2C%20Ducher%2C%20V.%2C%20Hewison%2C%20C.%2C%20Ibrahim%2C%20M.%2C%20Lebeau%2C%20K.%2C%20Mazmanian%2C%20M.%2C%20Mirzayeva%2C%20R.%2C%20Moreau%2C%20M.%2C%20Moschioni%2C%20M.%2C%20P%26%23xE2%3Bquet%2C%20A.%2C%20Perrin%2C%20C.%2C%20Pichon%2C%20L.%2C%20Roussel%2C%20J.%2C%20Scotton%2C%20M.%2C%20Austin%2C%20A.%20and%20Sun%2C%20P.%20%282025%29.%20%26lt%3Bb%26gt%3BBedaquiline%2C%20delamanid%2C%20linezolid%2C%20and%20clofazimine%20for%20rifampicin-resistant%20and%20fluoroquinolone-resistant%20tuberculosis%20%28endTB-Q%29%3A%20an%20open-label%2C%20multicentre%2C%20stratified%2C%20non-inferiority%2C%20randomised%2C%20controlled%2C%20phase%203%20trial%26lt%3B%5C%2Fb%26gt%3B.%20The%20Lancet%20Respiratory%20Medicine%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS2213-2600%2825%2900194-8%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS2213-2600%2825%2900194-8%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Bedaquiline%2C%20delamanid%2C%20linezolid%2C%20and%20clofazimine%20for%20rifampicin-resistant%20and%20fluoroquinolone-resistant%20tuberculosis%20%28endTB-Q%29%3A%20an%20open-label%2C%20multicentre%2C%20stratified%2C%20non-inferiority%2C%20randomised%2C%20controlled%2C%20phase%203%20trial%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Uzma%22%2C%22lastName%22%3A%22Khan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gustavo%20E%22%2C%22lastName%22%3A%22Vel%5Cu00e1squez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maelenn%22%2C%22lastName%22%3A%22Gouillou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muhammad%20Hammad%22%2C%22lastName%22%3A%22Ali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samreen%22%2C%22lastName%22%3A%22Amjad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Farees%22%2C%22lastName%22%3A%22Kamal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amanzhan%22%2C%22lastName%22%3A%22Abubakirov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elisa%22%2C%22lastName%22%3A%22Ardizzoni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elisabeth%22%2C%22lastName%22%3A%22Baudin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sagit%22%2C%22lastName%22%3A%22Bektassov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22Berry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maryline%22%2C%22lastName%22%3A%22Bonnet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vijay%22%2C%22lastName%22%3A%22Chavan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvine%22%2C%22lastName%22%3A%22Coutisson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhanna%22%2C%22lastName%22%3A%22Dakenova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bouke%20Catherine%22%2C%22lastName%22%3A%22de%20Jong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luong%20Van%22%2C%22lastName%22%3A%22Dinh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriella%22%2C%22lastName%22%3A%22Ferlazzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ohanna%22%2C%22lastName%22%3A%22Kirakosyan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%22%2C%22lastName%22%3A%22Lachenal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leonid%22%2C%22lastName%22%3A%22Lecca%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helen%22%2C%22lastName%22%3A%22McIlleron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kwabisha%20Kunda%22%2C%22lastName%22%3A%22Mikanda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sergio%22%2C%22lastName%22%3A%22Mucching-Toscano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wim%22%2C%22lastName%22%3A%22Mulders%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hebah%22%2C%22lastName%22%3A%22Mushtaque%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Payam%22%2C%22lastName%22%3A%22Nahid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dong%20Van%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nhung%20Viet%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lawrence%22%2C%22lastName%22%3A%22Oyewusi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ilaria%22%2C%22lastName%22%3A%22Motta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samiran%22%2C%22lastName%22%3A%22Panda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandip%22%2C%22lastName%22%3A%22Patil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thuong%20Huu%22%2C%22lastName%22%3A%22Pham%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dat%20Thuong%22%2C%22lastName%22%3A%22Phan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ha%20Thi%20Thu%22%2C%22lastName%22%3A%22Phan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20P%20J%22%2C%22lastName%22%3A%22Phillips%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jimena%22%2C%22lastName%22%3A%22Ruiz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Praharshinie%22%2C%22lastName%22%3A%22Rupasinghe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naseem%22%2C%22lastName%22%3A%22Salahuddin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Epifanio%22%2C%22lastName%22%3A%22Sanchez-Garavito%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kwonjune%20J%22%2C%22lastName%22%3A%22Seung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meseret%20Tamirat%22%2C%22lastName%22%3A%22Asfaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dante%22%2C%22lastName%22%3A%22Vargas%20Vasquez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20L%22%2C%22lastName%22%3A%22Rich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francis%22%2C%22lastName%22%3A%22Varaine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carole%20D%22%2C%22lastName%22%3A%22Mitnick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gurpreet%22%2C%22lastName%22%3A%22Arora%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valay%22%2C%22lastName%22%3A%22Ashara%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sonali%22%2C%22lastName%22%3A%22Bhattacharjee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rakshanda%22%2C%22lastName%22%3A%22Borkar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Namita%22%2C%22lastName%22%3A%22Chincholikar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nikita%22%2C%22lastName%22%3A%22Choudhary%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Praveen%22%2C%22lastName%22%3A%22Davuluri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neha%22%2C%22lastName%22%3A%22Desai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Dipika%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sunil%22%2C%22lastName%22%3A%22Dhongade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Drishti%22%2C%22lastName%22%3A%22Dulani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sheetal%22%2C%22lastName%22%3A%22Ghule%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nilma%22%2C%22lastName%22%3A%22Hirani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Prakash%22%2C%22lastName%22%3A%22Hurali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reeana%22%2C%22lastName%22%3A%22Irani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kiran%22%2C%22lastName%22%3A%22Jadhav%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pritesh%22%2C%22lastName%22%3A%22Jadhav%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Radhika%22%2C%22lastName%22%3A%22Jadhav%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nidhin%22%2C%22lastName%22%3A%22Joseph%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Akshay%22%2C%22lastName%22%3A%22Joshi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pranav%22%2C%22lastName%22%3A%22Joshi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Akhilraj%22%2C%22lastName%22%3A%22K%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sagar%22%2C%22lastName%22%3A%22K%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Madhavi%22%2C%22lastName%22%3A%22Kamble%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rashmi%22%2C%22lastName%22%3A%22Kate%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tanvi%22%2C%22lastName%22%3A%22Keer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Madhuri%22%2C%22lastName%22%3A%22S%20Kenche%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Harsha%22%2C%22lastName%22%3A%22Khandare%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pranesha%22%2C%22lastName%22%3A%22Koli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Apurva%22%2C%22lastName%22%3A%22Kulkarni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sagar%20Kumar%22%2C%22lastName%22%3A%22Patra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abhishek%22%2C%22lastName%22%3A%22Kuwar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Prakash%22%2C%22lastName%22%3A%22Lande%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nana%22%2C%22lastName%22%3A%22Mane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Priya%22%2C%22lastName%22%3A%22Masalge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Priya%22%2C%22lastName%22%3A%22Mishra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rishabh%22%2C%22lastName%22%3A%22Mitkari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajit%22%2C%22lastName%22%3A%22More%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pracheta%22%2C%22lastName%22%3A%22Munot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ramya%22%2C%22lastName%22%3A%22Murgesh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sagar%22%2C%22lastName%22%3A%22Muthe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nupur%22%2C%22lastName%22%3A%22Nakashe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dwaragesh%22%2C%22lastName%22%3A%22Natarajan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sharad%22%2C%22lastName%22%3A%22Paril%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Supriya%22%2C%22lastName%22%3A%22Patil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vaishali%22%2C%22lastName%22%3A%22Patil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vaijayanti%22%2C%22lastName%22%3A%22Patwardhan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vivek%22%2C%22lastName%22%3A%22Posture%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anil%22%2C%22lastName%22%3A%22Pradeshi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanya%22%2C%22lastName%22%3A%22Prasad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bhavya%22%2C%22lastName%22%3A%22Pundir%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarathi%22%2C%22lastName%22%3A%22Rajendran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yogesh%22%2C%22lastName%22%3A%22Randhit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Rekart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pradnya%22%2C%22lastName%22%3A%22Samant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hanif%22%2C%22lastName%22%3A%22Shaikh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ashutosh%22%2C%22lastName%22%3A%22Sharma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neela%22%2C%22lastName%22%3A%22Sharma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sharda%22%2C%22lastName%22%3A%22Sharma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nilesh%22%2C%22lastName%22%3A%22Shinde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Suvarna%22%2C%22lastName%22%3A%22Shinde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gauri%22%2C%22lastName%22%3A%22Shingare%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abhay%22%2C%22lastName%22%3A%22Shulka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aniket%22%2C%22lastName%22%3A%22Shriwas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lokesh%22%2C%22lastName%22%3A%22Sonawane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Urmila%22%2C%22lastName%22%3A%22Sudhindra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dipali%22%2C%22lastName%22%3A%22Suryavanshi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Akshay%22%2C%22lastName%22%3A%22Thakare%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Danashree%22%2C%22lastName%22%3A%22Udare%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gayatri%22%2C%22lastName%22%3A%22Vaidya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rani%22%2C%22lastName%22%3A%22Wagh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lyazzat%22%2C%22lastName%22%3A%22Isenova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gulbakhar%22%2C%22lastName%22%3A%22Konigratbayeva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gulnar%22%2C%22lastName%22%3A%22Nurtayeva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nurlan%22%2C%22lastName%22%3A%22Zekeshov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Romain%22%2C%22lastName%22%3A%22Chenu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Souna%22%2C%22lastName%22%3A%22Garba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daiane%22%2C%22lastName%22%3A%22Tozzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francis-Jaudel%22%2C%22lastName%22%3A%22Yuya-Septoh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bui%22%2C%22lastName%22%3A%22Thi%20Tuyet%20Mai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dang%22%2C%22lastName%22%3A%22Thi%20Hai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dinh%22%2C%22lastName%22%3A%22Thi%20Thuy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lai%22%2C%22lastName%22%3A%22Thi%20Oanh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bang%20Tam%22%2C%22lastName%22%3A%22Do%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dinh%20Tuyen%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Phuong%20Hoang%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thi%20Mai%20Anh%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thi%20Thuy%20Hanh%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thi%20Kieu%20Ninh%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thi%20Nhien%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Van%20Khiem%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nog%22%2C%22lastName%22%3A%22Nog%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thanh%20Nam%22%2C%22lastName%22%3A%22Pham%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thi%20Lan%22%2C%22lastName%22%3A%22Pham%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thu%20Anh%22%2C%22lastName%22%3A%22Pham%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thi%20Bich%22%2C%22lastName%22%3A%22Phung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bao%20Trung%22%2C%22lastName%22%3A%22Tran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Minh%20Trang%22%2C%22lastName%22%3A%22Trinh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eva%22%2C%22lastName%22%3A%22Chang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julia%22%2C%22lastName%22%3A%22Coit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacquelyn-My%22%2C%22lastName%22%3A%22Do%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Allison%22%2C%22lastName%22%3A%22LaHood%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kelsey%22%2C%22lastName%22%3A%22O%27Brien%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Enoma%22%2C%22lastName%22%3A%22Okunbor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elna%22%2C%22lastName%22%3A%22Osso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Victor%22%2C%22lastName%22%3A%22Ch%5Cu00e1vez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Piero%22%2C%22lastName%22%3A%22Larco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Mendoza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%22%2C%22lastName%22%3A%22Robles%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angelo%22%2C%22lastName%22%3A%22Rojas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Janet%22%2C%22lastName%22%3A%22Salazar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriela%22%2C%22lastName%22%3A%22Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%22%2C%22lastName%22%3A%22Sosa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cesar%22%2C%22lastName%22%3A%22Ticona%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shirley%22%2C%22lastName%22%3A%22Carranza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Diego%22%2C%22lastName%22%3A%22Delgado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cemir%22%2C%22lastName%22%3A%22Galarza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gladys%22%2C%22lastName%22%3A%22Murga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%22%2C%22lastName%22%3A%22Ramos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kelly%22%2C%22lastName%22%3A%22Cantaro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrely%22%2C%22lastName%22%3A%22Huerta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Maldonado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roberto%22%2C%22lastName%22%3A%22Nu%5Cu00f1ez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katherine%22%2C%22lastName%22%3A%22Panduro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ruth%22%2C%22lastName%22%3A%22Rafael%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amaan%22%2C%22lastName%22%3A%22Abdul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%22%2C%22lastName%22%3A%22Abedin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eraj%22%2C%22lastName%22%3A%22Afreen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sohail%22%2C%22lastName%22%3A%22Ahmed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ubaid%22%2C%22lastName%22%3A%22Ahmed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jinsar%22%2C%22lastName%22%3A%22Ali%20Shah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Azka%22%2C%22lastName%22%3A%22Ashraf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faisal%22%2C%22lastName%22%3A%22Aslam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zahida%22%2C%22lastName%22%3A%22Bashir%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Saba%22%2C%22lastName%22%3A%22Fayyaz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kiren%22%2C%22lastName%22%3A%22Hafeez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meherunissa%22%2C%22lastName%22%3A%22Hamid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Basmah%22%2C%22lastName%22%3A%22Hassan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muzamil%22%2C%22lastName%22%3A%22Hussain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muhammad%22%2C%22lastName%22%3A%22Irfan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%22%2C%22lastName%22%3A%22Omar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shafiqua%22%2C%22lastName%22%3A%22Parveen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sharoon%22%2C%22lastName%22%3A%22Sunail%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muhammad%22%2C%22lastName%22%3A%22Farooq%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Batool%22%2C%22lastName%22%3A%22Mazhar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sana%22%2C%22lastName%22%3A%22Munir%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neelofer%22%2C%22lastName%22%3A%22Sonia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muhammad%22%2C%22lastName%22%3A%22Yaseen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muhammad%22%2C%22lastName%22%3A%22Zubair%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fatima%22%2C%22lastName%22%3A%22Zehra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Iqra%22%2C%22lastName%22%3A%22Zulfiqar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tazeen%22%2C%22lastName%22%3A%22Abbasi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ghulam%22%2C%22lastName%22%3A%22Akbar%20Abro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mushtaque%22%2C%22lastName%22%3A%22Ahmed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nazir%22%2C%22lastName%22%3A%22Ahmed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muhammad%22%2C%22lastName%22%3A%22Hammad%20Ali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nazakat%22%2C%22lastName%22%3A%22Ali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rao%22%2C%22lastName%22%3A%22Danish%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ayesha%22%2C%22lastName%22%3A%22Farhat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sunaina%22%2C%22lastName%22%3A%22Gill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muhammad%22%2C%22lastName%22%3A%22Hafeez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ghulam%22%2C%22lastName%22%3A%22Hussain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Habib%22%2C%22lastName%22%3A%22Inayat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvia%22%2C%22lastName%22%3A%22Johnson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Farees%22%2C%22lastName%22%3A%22Kamal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adil%22%2C%22lastName%22%3A%22Kamran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sanjeet%22%2C%22lastName%22%3A%22Kumar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mahveer%22%2C%22lastName%22%3A%22Maheshwari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shahid%22%2C%22lastName%22%3A%22Mamsa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sumera%22%2C%22lastName%22%3A%22Massey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Asif%22%2C%22lastName%22%3A%22Mehmood%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aaisha%22%2C%22lastName%22%3A%22Memon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ayaz%22%2C%22lastName%22%3A%22Ali%20Mirani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shafaque%22%2C%22lastName%22%3A%22Naz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tanzeel%22%2C%22lastName%22%3A%22Rafique%20Qureshi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yash%22%2C%22lastName%22%3A%22Roop%20Moazzam%20Sheikh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muhammad%22%2C%22lastName%22%3A%22Rafi%20Siddiqui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bhom%22%2C%22lastName%22%3A%22Singh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mustajab%22%2C%22lastName%22%3A%22Soomro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elisa%22%2C%22lastName%22%3A%22Ardizzoni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leen%22%2C%22lastName%22%3A%22Rigouts%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Praha%22%2C%22lastName%22%3A%22Rupasinghe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annum%22%2C%22lastName%22%3A%22Aftab%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Saman%22%2C%22lastName%22%3A%22Ahmed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muhammad%22%2C%22lastName%22%3A%22Adnan%20Alamgir%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ayaz%22%2C%22lastName%22%3A%22Ali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Azhar%22%2C%22lastName%22%3A%22Ali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shahzaib%22%2C%22lastName%22%3A%22Ahmed%20Ali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sakhawat%22%2C%22lastName%22%3A%22Ali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sanam%22%2C%22lastName%22%3A%22Altaf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samreen%22%2C%22lastName%22%3A%22Amjad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mahnoor%22%2C%22lastName%22%3A%22Sahiba%20Arshad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sadia%22%2C%22lastName%22%3A%22Ausim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abdul%22%2C%22lastName%22%3A%22Basit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Haroon%22%2C%22lastName%22%3A%22Ezik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hira%22%2C%22lastName%22%3A%22Hussain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sibtain%22%2C%22lastName%22%3A%22Hyder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shahzad%22%2C%22lastName%22%3A%22Inayat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aleeza%22%2C%22lastName%22%3A%22Janmohammed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Komal%22%2C%22lastName%22%3A%22Jaseem%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aqsa%22%2C%22lastName%22%3A%22Jawed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lamis%22%2C%22lastName%22%3A%22Maniar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pardeep%22%2C%22lastName%22%3A%22Kumar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Susheel%22%2C%22lastName%22%3A%22Kumar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reema%22%2C%22lastName%22%3A%22Latif%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%22%2C%22lastName%22%3A%22Liaqat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muhammad%22%2C%22lastName%22%3A%22Ammar%20Nasser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muhammad%22%2C%22lastName%22%3A%22Shakeel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shahzaib%22%2C%22lastName%22%3A%22Shaikh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anique%22%2C%22lastName%22%3A%22Siddiqui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jetmal%22%2C%22lastName%22%3A%22Singh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Koushalia%22%2C%22lastName%22%3A%22Sivan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Momal%22%2C%22lastName%22%3A%22Taimoor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nabeel%22%2C%22lastName%22%3A%22Zia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Inessa%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Merei%22%2C%22lastName%22%3A%22Otepbergenova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thu%20Huong%22%2C%22lastName%22%3A%22Dinh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thi%20Thu%22%2C%22lastName%22%3A%22Do%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thu%20Thuong%22%2C%22lastName%22%3A%22Do%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thi%20Nguyet%22%2C%22lastName%22%3A%22Le%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kim%20Cuong%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thi%20Thuy%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Van%20Hung%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gaukhar%22%2C%22lastName%22%3A%22Abildayeva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Orazbayeva%22%2C%22lastName%22%3A%22Maryash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elena%22%2C%22lastName%22%3A%22Telegina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lyailya%22%2C%22lastName%22%3A%22Tursynbekova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhanelya%22%2C%22lastName%22%3A%22Amanzholova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Perizat%22%2C%22lastName%22%3A%22Bektassova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anel%22%2C%22lastName%22%3A%22Belgozhanova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nazerke%22%2C%22lastName%22%3A%22Birimkulova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nurgul%22%2C%22lastName%22%3A%22Dyusebayeva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nilay%22%2C%22lastName%22%3A%22Erkut%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arnur%22%2C%22lastName%22%3A%22Gusmanov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Banu%22%2C%22lastName%22%3A%22Kassenova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aigerim%22%2C%22lastName%22%3A%22Kassym%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kanat%22%2C%22lastName%22%3A%22Khazhidinov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tatyana%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Azhar%22%2C%22lastName%22%3A%22Magzumova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Moldir%22%2C%22lastName%22%3A%22Mussabayeva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gulnar%22%2C%22lastName%22%3A%22Omarova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nadezhda%22%2C%22lastName%22%3A%22Ryapolova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lyazzat%22%2C%22lastName%22%3A%22Sagyndykova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Asel%22%2C%22lastName%22%3A%22Serekbay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Assel%22%2C%22lastName%22%3A%22Stambekova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gulmira%22%2C%22lastName%22%3A%22Tanatarova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zinatdin%22%2C%22lastName%22%3A%22Uaisov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhanel%22%2C%22lastName%22%3A%22Zhantuarova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gulnara%22%2C%22lastName%22%3A%22Zhumakairova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nataliya%22%2C%22lastName%22%3A%22Arlyapova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%22%2C%22lastName%22%3A%22Bogus%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meredith%22%2C%22lastName%22%3A%22Cain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Merida%22%2C%22lastName%22%3A%22Carmona%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clare%22%2C%22lastName%22%3A%22Flanagan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22McAnaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alyssa%22%2C%22lastName%22%3A%22Scharff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sonya%22%2C%22lastName%22%3A%22Soni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Megan%22%2C%22lastName%22%3A%22Striplin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Seyfu%22%2C%22lastName%22%3A%22Abebe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johnson%22%2C%22lastName%22%3A%22Alakaye%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Atang%22%2C%22lastName%22%3A%22Bulane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Custodio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Precious%22%2C%22lastName%22%3A%22Hajison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Malefetsane%22%2C%22lastName%22%3A%22Hetsa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Holtzman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matlotliso%22%2C%22lastName%22%3A%22Khesa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Makatleho%22%2C%22lastName%22%3A%22Lethola%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Talime%22%2C%22lastName%22%3A%22Lebitsa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mpho%22%2C%22lastName%22%3A%22Mahamo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joalane%22%2C%22lastName%22%3A%22Makaka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mokenyakenya%22%2C%22lastName%22%3A%22Matoko%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephane%22%2C%22lastName%22%3A%22Mpinda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Polo%22%2C%22lastName%22%3A%22Mohoang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Monyaesa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%22%2C%22lastName%22%3A%22Nkundayirazo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mabohlokoa%22%2C%22lastName%22%3A%22Ntsane%20Sesomo%20Mohale%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Seabata%22%2C%22lastName%22%3A%22Ntsibane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sebakeng%22%2C%22lastName%22%3A%22Phate%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mathemba%22%2C%22lastName%22%3A%22Radebe%20%28Retsepile%20Tlali%29%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Moliehi%22%2C%22lastName%22%3A%22Rakhetsi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tello%22%2C%22lastName%22%3A%22Ranoosi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meseret%22%2C%22lastName%22%3A%22Tamirat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mahooe%22%2C%22lastName%22%3A%22Thokoana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ericka%22%2C%22lastName%22%3A%22Alegre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%22%2C%22lastName%22%3A%22Aguilar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lourdes%22%2C%22lastName%22%3A%22Armuto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nadia%22%2C%22lastName%22%3A%22Barreda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%22%2C%22lastName%22%3A%22Barreto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%22%2C%22lastName%22%3A%22Cabrera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roger%22%2C%22lastName%22%3A%22Calderon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Milagros%22%2C%22lastName%22%3A%22Castro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jelina%22%2C%22lastName%22%3A%22Chavez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%22%2C%22lastName%22%3A%22Chavez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Haydee%22%2C%22lastName%22%3A%22Cheje%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lesli%22%2C%22lastName%22%3A%22Cori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22D%5Cu00e1valos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Silvana%22%2C%22lastName%22%3A%22de%20la%20Gala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%22%2C%22lastName%22%3A%22Delgadillo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hannely%22%2C%22lastName%22%3A%22Diaz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ximena%22%2C%22lastName%22%3A%22Flores%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jimmy%22%2C%22lastName%22%3A%22Galarza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dalicxa%22%2C%22lastName%22%3A%22Garc%5Cu00eda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fanny%22%2C%22lastName%22%3A%22Garcia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miriam%22%2C%22lastName%22%3A%22Gaspar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roselena%22%2C%22lastName%22%3A%22Godos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pamela%22%2C%22lastName%22%3A%22Gomez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luz%22%2C%22lastName%22%3A%22Gonzales%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lizsery%22%2C%22lastName%22%3A%22Guerrero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sadith%22%2C%22lastName%22%3A%22Inga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Judith%22%2C%22lastName%22%3A%22Jasaycucho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%22%2C%22lastName%22%3A%22Martel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%22%2C%22lastName%22%3A%22Pro%20Martinez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raquel%22%2C%22lastName%22%3A%22Molina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raquel%22%2C%22lastName%22%3A%22Mugruza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hansel%22%2C%22lastName%22%3A%22Mundaca%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Merilyn%22%2C%22lastName%22%3A%22Nuahan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%22%2C%22lastName%22%3A%22Ore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liliana%22%2C%22lastName%22%3A%22Panduro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olga%22%2C%22lastName%22%3A%22Pe%5Cu00f1a%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%22%2C%22lastName%22%3A%22Perea%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cynthia%22%2C%22lastName%22%3A%22Pinedo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yhomay%22%2C%22lastName%22%3A%22Ponce%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%22%2C%22lastName%22%3A%22Quinte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maritza%22%2C%22lastName%22%3A%22Qui%5Cu00f1ones%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alicia%22%2C%22lastName%22%3A%22Ramos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elmer%22%2C%22lastName%22%3A%22Ramirez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rosina%22%2C%22lastName%22%3A%22Reynoso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cynthia%22%2C%22lastName%22%3A%22Reyes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%22%2C%22lastName%22%3A%22Reyes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%22%2C%22lastName%22%3A%22Riccio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%22%2C%22lastName%22%3A%22Robles%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%22%2C%22lastName%22%3A%22Rojas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Oswaldo%22%2C%22lastName%22%3A%22Sanabria%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%22%2C%22lastName%22%3A%22Saravia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Susana%22%2C%22lastName%22%3A%22Saravia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liz%22%2C%22lastName%22%3A%22Senador%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jose%22%2C%22lastName%22%3A%22Soberon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edith%22%2C%22lastName%22%3A%22Soncco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maribel%22%2C%22lastName%22%3A%22Soto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22Suarez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Milagros%22%2C%22lastName%22%3A%22Suarez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Veronica%22%2C%22lastName%22%3A%22Suarez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erika%22%2C%22lastName%22%3A%22Torpoco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Oscar%22%2C%22lastName%22%3A%22Torres%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%22%2C%22lastName%22%3A%22Torrez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriela%22%2C%22lastName%22%3A%22Tunque%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aida%22%2C%22lastName%22%3A%22Ugarte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gissela%22%2C%22lastName%22%3A%22Vaderrama%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%22%2C%22lastName%22%3A%22Valdivia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yesica%22%2C%22lastName%22%3A%22Valdivia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabel%22%2C%22lastName%22%3A%22Valverde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cynthia%22%2C%22lastName%22%3A%22Vargas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Janet%22%2C%22lastName%22%3A%22Vargas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elvia%22%2C%22lastName%22%3A%22Vasquez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%22%2C%22lastName%22%3A%22Veliz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dioselinda%22%2C%22lastName%22%3A%22Villa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sheyla%22%2C%22lastName%22%3A%22Villafuerte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Geraldine%22%2C%22lastName%22%3A%22Villar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephanie%22%2C%22lastName%22%3A%22Villegas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Milagros%22%2C%22lastName%22%3A%22Wong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rosa%22%2C%22lastName%22%3A%22Yataco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hang%22%2C%22lastName%22%3A%22Pham%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hieu%22%2C%22lastName%22%3A%22Truong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hai%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vo%22%2C%22lastName%22%3A%22Huy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Van%20Song%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thi%20Minh%20Khai%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Trung%22%2C%22lastName%22%3A%22Minh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Duyen%20Thanh%20Thao%22%2C%22lastName%22%3A%22Bui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Van%20Vinh%22%2C%22lastName%22%3A%22Truong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thi%20Thu%20Ha%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvine%22%2C%22lastName%22%3A%22Coutisson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melchior%22%2C%22lastName%22%3A%22Atger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandra%22%2C%22lastName%22%3A%22Nadia%20Baya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marwa%22%2C%22lastName%22%3A%22Bekhiet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Veronique%22%2C%22lastName%22%3A%22Boissi%5Cu00e8re%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roberta%22%2C%22lastName%22%3A%22Caboclo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marhaba%22%2C%22lastName%22%3A%22Chaudhry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandrine%22%2C%22lastName%22%3A%22Cloez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandra%22%2C%22lastName%22%3A%22Collin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%5Cu00e9line%22%2C%22lastName%22%3A%22Delifer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shana%22%2C%22lastName%22%3A%22Demaisons%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%22%2C%22lastName%22%3A%22Ducher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cathy%22%2C%22lastName%22%3A%22Hewison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohamed%22%2C%22lastName%22%3A%22Ibrahim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristen%22%2C%22lastName%22%3A%22Lebeau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Merry%22%2C%22lastName%22%3A%22Mazmanian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rada%22%2C%22lastName%22%3A%22Mirzayeva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mathilde%22%2C%22lastName%22%3A%22Moreau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Monica%22%2C%22lastName%22%3A%22Moschioni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Audrey%22%2C%22lastName%22%3A%22P%5Cu00e2quet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christophe%22%2C%22lastName%22%3A%22Perrin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%22%2C%22lastName%22%3A%22Pichon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeanne%22%2C%22lastName%22%3A%22Roussel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martina%22%2C%22lastName%22%3A%22Scotton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ariana%22%2C%22lastName%22%3A%22Austin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pearl%22%2C%22lastName%22%3A%22Sun%22%7D%5D%2C%22abstractNote%22%3A%22Background%5CnPre-extensively%20drug-resistant%20%28pre-XDR%29%20tuberculosis%20%28ie%2C%20multidrug-resistant%20or%20rifampicin-resistant%20with%20additional%20resistance%20to%20any%20fluoroquinolone%29%20is%20difficult%20to%20treat.%20endTB-Q%20aimed%20to%20evaluate%20the%20efficacy%20and%20safety%20of%20bedaquiline%2C%20delamanid%2C%20linezolid%2C%20and%20clofazimine%20%28BDLC%29%20compared%20with%20the%20standard%20of%20care%20for%20patients%20with%20pre-XDR%20tuberculosis.%5CnMethods%5CnThis%20open-label%2C%20multicentre%2C%20stratified%2C%20non-inferiority%2C%20randomised%2C%20controlled%2C%20phase%203%20trial%20was%20conducted%20in%20ten%20hospitals%20in%20India%2C%20Kazakhstan%2C%20Lesotho%2C%20Pakistan%2C%20Peru%2C%20and%20Viet%20Nam.%20Participants%20aged%2015%20years%20or%20older%20who%20had%20pulmonary%20tuberculosis%20with%20resistance%20to%20rifampicin%20and%20fluoroquinolones%20were%20included.%20Participants%20were%20randomly%20assigned%20%282%3A1%29%20to%20the%20BDLC%20group%20%28all-oral%20bedaquiline%20400%20mg%20once%20per%20day%20for%202%20weeks%20followed%20by%20200%20mg%20three%20times%20per%20week%2C%20delamanid%20100%20mg%20twice%20per%20day%2C%20linezolid%20600%20mg%20once%20per%20day%20for%2016%20weeks%20and%20then%20either%20300%20mg%20once%20per%20day%20or%20600%20mg%20three%20times%20per%20week%2C%20and%20clofazimine%20100%20mg%20once%20per%20day%29%20or%20the%20control%20group%20%28individualised%20WHO-recommended%20longer%20standard%20of%20care%29.%20Randomisation%20was%20stratified%20by%20country%20and%20baseline%20disease%20extent.%20BDLC%20was%20administered%20for%2039%20weeks%20%289-month%20regimen%29%20for%20extensive%20disease%20and%2024%20weeks%20%286-month%20regimen%29%20for%20limited%20disease%20and%20extended%20to%209%20months%20for%20those%20with%20a%20positive%20culture%20at%208%20weeks%20or%20later%20or%20a%20missing%208-week%20culture%20result.%20Site%20staff%20and%20participants%20were%20not%20masked%2C%20whereas%20investigators%20and%20laboratory%20staff%20were%20masked%20to%20treatment%20assignment.%20The%20primary%20endpoint%20was%20favourable%20outcome%20%28two%20consecutive%2C%20negative%20cultures%20including%20one%20between%20weeks%2065%20and%2073%3B%20or%20favourable%20bacteriological%2C%20radiological%2C%20and%20clinical%20evolution%29%20at%20week%2073%20after%20randomisation%20in%20the%20modified%20intention-to-treat%20%28mITT%29%20and%20per-protocol%20populations.%20We%20report%20the%20risk%20differences%20adjusted%20for%20stratification%20variables%2C%20with%20a%20non-inferiority%20margin%20of%20%5Cu201312%25.%20This%20trial%20is%20registered%20with%20ClinicalTrials.gov%2C%20NCT03896685.%5CnFindings%5CnBetween%20April%204%2C%202020%2C%20and%20March%2028%2C%202023%2C%201030%20individuals%20were%20screened%20and%20324%20%2831%25%29%20were%20randomly%20assigned%20%28219%20to%20the%20BDLC%20group%20and%20105%20to%20the%20control%20group%29.%20114%20%2846%25%29%20participants%20were%20female%20and%20133%20%2854%25%29%20were%20male.%20Median%20age%20was%2030%5Cu00b75%20years%20%28IQR%2021%5Cu00b76%5Cu201343%5Cu00b70%29.%20157%20%2864%25%29%20participants%20had%20extensive%20disease%20at%20baseline.%20In%20the%20BDLC%20group%2C%2047%20%2829%25%29%20of%20163%20were%20assigned%20to%20receive%20the%206-month%20regimen%20and%20116%20%2871%25%29%20the%209-month%20regimen.%20The%20core%20regimen%20of%20BDLC%20plus%20one%20or%20more%20other%20drugs%20was%20used%20for%2076%20%2891%25%29%20of%2084%20participants%20in%20the%20control%20group.%20At%20week%2073%2C%20favourable%20outcome%20was%20reached%20by%20141%20%2887%25%29%20participants%20in%20the%20BDLC%20group%20versus%2075%20%2889%25%29%20in%20the%20control%20group%20in%20the%20mITT%20population%20%28adjusted%20risk%20difference%200%5Cu00b72%25%20%5B95%25%20CI%20%5Cu20139%5Cu00b71%20to%209%5Cu00b75%5D%3B%20pnon-inferiority%3D0%5Cu00b70051%29%20and%20by%20138%20%2888%25%29%20of%20157%20versus%2071%20%2893%25%29%20of%2076%20in%20the%20per-protocol%20population%20%28adjusted%20risk%20difference%20%5Cu20133%5Cu00b75%25%20%5B%5Cu201312%5Cu00b78%20to%205%5Cu00b79%5D%3B%20pnon-inferiority%3D0%5Cu00b7037%29.%20Overall%20non-inferiority%20was%20not%20shown.%20145%20%2868%25%29%20of%20213%20participants%20in%20the%20BDLC%20group%20and%2077%20%2873%25%29%20of%20105%20in%20the%20control%20group%20had%20at%20least%20one%20grade%203%20or%20higher%20adverse%20event%2C%20with%20eight%20%284%25%29%20and%20two%20%282%25%29%20all-cause%20deaths%20by%20week%2073%2C%20respectively.%5CnInterpretation%5CnThe%20shortened%20BDLC%20strategy%20was%20not%20non-inferior%20to%20the%20control.%20Accumulating%20evidence%20suggests%20that%20this%20patient%20population%20might%20require%20longer%2C%20reinforced%20regimens.%5CnFunding%5CnUnitaid%2C%20M%5Cu00e9decins%20Sans%20Fronti%5Cu00e8res%2C%20Partners%20In%20Health%2C%20Interactive%20Research%20and%20Development%2C%20Ram%5Cu00f3n%20Areces%20Foundation%2C%20the%20Jung%20Foundation%20for%20Science%20and%20Research%2C%20Research%20Foundation-Flanders.%5CnTranslations%5CnFor%20the%20Hindi%2C%20Marathi%2C%20Spanish%2C%20Vietnamese%2C%20Russian%2C%20Urdu%20and%20French%20translations%20of%20the%20abstract%20see%20Supplementary%20Materials%20section.%22%2C%22date%22%3A%222025-07-16%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2FS2213-2600%2825%2900194-8%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS2213260025001948%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%222213-2600%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-08-21T13%3A27%3A16Z%22%7D%7D%2C%7B%22key%22%3A%22MV2MSRDB%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Guthmann%20et%20al.%22%2C%22parsedDate%22%3A%222025%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGuthmann%2C%20J.-P.%2C%20Robert%2C%20J.%2C%20Viriot%2C%20D.%20and%20Parent%20Du%20Chatelet%2C%20I.%20%282025%29.%20%26lt%3Bb%26gt%3BIncidence%2C%20severity%20and%20treatment%20outcome%20of%20tuberculosis%20in%20the%20era%20of%20the%20COVID-19%20pandemic%2C%20France%2C%202018%26%23x2013%3B2023%26lt%3B%5C%2Fb%26gt%3B.%20Journal%20of%20Epidemiology%20and%20Population%20Health%20%26lt%3Bi%26gt%3B73%26lt%3B%5C%2Fi%26gt%3B%2C%20202795%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jeph.2024.202795%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jeph.2024.202795%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Incidence%2C%20severity%20and%20treatment%20outcome%20of%20tuberculosis%20in%20the%20era%20of%20the%20COVID-19%20pandemic%2C%20France%2C%202018%5Cu20132023%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Paul%22%2C%22lastName%22%3A%22Guthmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00e9r%5Cu00f4me%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Delphine%22%2C%22lastName%22%3A%22Viriot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabelle%22%2C%22lastName%22%3A%22Parent%20Du%20Chatelet%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2202%5C%2F2025%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jeph.2024.202795%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS2950433324006049%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%2229504333%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-02-13T10%3A17%3A53Z%22%7D%7D%2C%7B%22key%22%3A%22ZBS2PH6C%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Hillemann%20et%20al.%22%2C%22parsedDate%22%3A%222025-07-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BHillemann%2C%20D.%2C%20Cambau%2C%20E.%2C%20Polsfu%26%23xDF%3B%2C%20S.%20and%20Friesen%2C%20I.%20%282025%29.%20%26lt%3Bb%26gt%3BComparison%20of%20a%20modified%20broth%20microdilution%20Sensititre%26lt%3Bsup%26gt%3BTM%26lt%3B%5C%2Fsup%26gt%3B%20SLOMYCOI%20assay%20with%20the%20CLSI-recommended%20agar%20disk%20elution%20method%20for%20antimicrobial%20susceptibility%20testing%20of%20%26lt%3Bi%26gt%3BMycobacterium%20haemophilum%26lt%3B%5C%2Fi%26gt%3B%26lt%3B%5C%2Fb%26gt%3B.%20Journal%20of%20Antimicrobial%20Chemotherapy%20%26lt%3Bi%26gt%3B80%26lt%3B%5C%2Fi%26gt%3B%2C%201993%26%23x2013%3B1996%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fjac%5C%2Fdkaf162%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fjac%5C%2Fdkaf162%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Comparison%20of%20a%20modified%20broth%20microdilution%20Sensititre%5Cu2122%20SLOMYCOI%20assay%20with%20the%20CLSI-recommended%20agar%20disk%20elution%20method%20for%20antimicrobial%20susceptibility%20testing%20of%20%3Ci%3EMycobacterium%20haemophilum%3C%5C%2Fi%3E%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Doris%22%2C%22lastName%22%3A%22Hillemann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Silke%22%2C%22lastName%22%3A%22Polsfu%5Cu00df%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Inna%22%2C%22lastName%22%3A%22Friesen%22%7D%5D%2C%22abstractNote%22%3A%22Abstract%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Objectives%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Mycobacterium%20haemophilum%20is%20a%20fastidious%20nontuberculous%20mycobacterium%20that%20causes%20severe%20infections%20in%20immunocompromised%20patients.%20Due%20to%20its%20complex%20growth%20requirements%2C%20its%20detection%20and%20antimicrobial%20susceptibility%20testing%20%28AST%29%20remain%20challenging.%20This%20study%20aimed%20to%20compare%20the%20performance%20of%20a%20modified%20commercial%20broth%20microdilution%20method%20%28Sensititre%5Cu2122%20Myco%20susceptibility%20plates%20with%20added%20haemin%29%20with%20the%20standard%20Clinical%20and%20Laboratory%20Standards%20Institute%20%28CLSI%29%20agar%20disk%20elution%20method%20for%20AST%20of%20M.%20haemophilum.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Methods%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20We%20conducted%2020%20comparative%20AST%20tests%20on%20M.%20haemophilum%20ATCC%2029548%20and%2010%20clinical%20isolates%2C%20using%20the%20CLSI%20agar%20disk%20elution%20method%20as%20the%20reference.%20MICs%20were%20determined%20using%20both%20methods%2C%20and%20categorical%20concordance%20was%20assessed%20for%20multiple%20antibiotics.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Results%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20The%20overall%20concordance%20between%20methods%20was%2081.4%25.%20High%20agreement%20was%20observed%20for%20clarithromycin%2C%20linezolid%2C%20trimethoprim-sulfamethoxazole%20and%20rifampicin%20%2890%25%5Cu2013100%25%29%2C%20while%20lower%20concordance%20was%20noted%20for%20amikacin%20%2840%25%29%2C%20ciprofloxacin%20%2875%25%29%20and%20doxycycline%20%2865%25%29.%20Sensititre%5Cu2122%20microdilution%20plates%20demonstrated%20superior%20standardization%2C%20ease%20of%20use%20and%20reduced%20contamination%20risks%20compared%20to%20the%20agar%20disk%20method.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Conclusions%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20The%20modified%20Sensititre%5Cu2122%20microdilution%20method%20is%20a%20reliable%20alternative%20to%20the%20agar%20disk%20elution%20method%20for%20AST%20of%20M.%20haemophilum.%20It%20provides%20precise%20MIC%20values%20and%20is%20better%20suited%20for%20routine%20clinical%20use%20due%20to%20improved%20reproducibility%20and%20efficiency.%22%2C%22date%22%3A%222025-07-01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1093%5C%2Fjac%5C%2Fdkaf162%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Facademic.oup.com%5C%2Fjac%5C%2Farticle%5C%2F80%5C%2F7%5C%2F1993%5C%2F8148914%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220305-7453%2C%201460-2091%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-09-30T15%3A01%3A54Z%22%7D%7D%2C%7B%22key%22%3A%22J8DRRQV9%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kherabi%20et%20al.%22%2C%22parsedDate%22%3A%222025-09%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKherabi%2C%20Y.%2C%20Skouvig%20Pedersen%2C%20O.%2C%20Lange%2C%20C.%2C%20B%26%23xE9%3Bn%26%23xE9%3Bzit%2C%20F.%2C%20Chesov%2C%20D.%2C%20Codecasa%2C%20L.%20R.%2C%20Dudnyk%2C%20A.%2C%20Kiria%2C%20N.%2C%20Konstantynovska%2C%20O.%2C%20Marigot-Outtandy%2C%20D.%2C%20Panciu%2C%20T.-C.%2C%20Poignon%2C%20C.%2C%20Sasi%2C%20S.%2C%20Schaub%2C%20D.%2C%20Solodovnikova%2C%20V.%2C%20Vasiliauskait%26%23xE8%3B%2C%20L.%2C%20Yeghiazaryan%2C%20L.%2C%20G%26%23xFC%3Bnther%2C%20G.%2C%20Guglielmetti%2C%20L.%20and%20TBnet%5C%2FESGMYC%20XDR-TB%20Study%20Group%20%282025%29.%20%26lt%3Bb%26gt%3BTreatment%20outcomes%20of%20extensively%20drug-resistant%20tuberculosis%20in%20Europe%3A%20a%20retrospective%20cohort%20study%26lt%3B%5C%2Fb%26gt%3B.%20Lancet%20Reg%20Health%20Eur%20%26lt%3Bi%26gt%3B56%26lt%3B%5C%2Fi%26gt%3B%2C%20101380%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.lanepe.2025.101380%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.lanepe.2025.101380%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Treatment%20outcomes%20of%20extensively%20drug-resistant%20tuberculosis%20in%20Europe%3A%20a%20retrospective%20cohort%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yousra%22%2C%22lastName%22%3A%22Kherabi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ole%22%2C%22lastName%22%3A%22Skouvig%20Pedersen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christoph%22%2C%22lastName%22%3A%22Lange%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fran%5Cu00e7ois%22%2C%22lastName%22%3A%22B%5Cu00e9n%5Cu00e9zit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dumitru%22%2C%22lastName%22%3A%22Chesov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luigi%20Ruffo%22%2C%22lastName%22%3A%22Codecasa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrii%22%2C%22lastName%22%3A%22Dudnyk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nana%22%2C%22lastName%22%3A%22Kiria%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olha%22%2C%22lastName%22%3A%22Konstantynovska%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dhiba%22%2C%22lastName%22%3A%22Marigot-Outtandy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Traian-Constantin%22%2C%22lastName%22%3A%22Panciu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Corentin%22%2C%22lastName%22%3A%22Poignon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sirje%22%2C%22lastName%22%3A%22Sasi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dagmar%22%2C%22lastName%22%3A%22Schaub%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Varvara%22%2C%22lastName%22%3A%22Solodovnikova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laima%22%2C%22lastName%22%3A%22Vasiliauskait%5Cu00e8%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lusine%22%2C%22lastName%22%3A%22Yeghiazaryan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gunar%22%2C%22lastName%22%3A%22G%5Cu00fcnther%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22TBnet%5C%2FESGMYC%20XDR-TB%20Study%20Group%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20In%202021%2C%20World%20Health%20Organization%20revised%20of%20definition%20of%20extensive%20drug-resistant%20tuberculosis.%20We%20aimed%20to%20determine%20treatment%20outcomes%20of%20individuals%20affected%20by%20extensively%20drug-resistant%20tuberculosis%20in%20Europe.%5CnMETHODS%3A%20This%20observational%2C%20retrospective%20cohort%20study%20included%20patients%20diagnosed%20with%20extensively%20drug-resistant%20tuberculosis%20in%20the%20World%20Health%20Organization%20European%20Region%20from%202017%20to%202023.%20Participating%20centres%20collected%20consecutive%2C%20detailed%20individual%20data%20for%20extensively%20drug-resistant%20tuberculosis%20patients.%20Data%20were%20analysed%20with%20meta-%20and%20regression%20methods%2C%20accounting%20for%20between-country%20heterogeneity.%5CnFINDINGS%3A%20Among%2011%2C003%20patients%20with%20multidrug-resistant%5C%2Frifampicin-resistant%20tuberculosis%2C%20188%20%281%5Cu00b77%25%29%20from%2016%20countries%20had%20extensively%20drug-resistant%20tuberculosis.%20Of%20these%2C%2048%5Cu00b74%25%20harboured%20strains%20with%20resistance%20to%20bedaquiline%20%28n%20%3D%2091%5C%2F188%29%2C%2034%5Cu00b70%25%20to%20linezolid%20%28n%20%3D%2064%5C%2F188%29%2C%20and%2017%5Cu00b76%25%20to%20both%20%28n%20%3D%2033%5C%2F188%29.%20The%20individual%20composition%20of%20anti-tuberculosis%20regimens%20was%20highly%20variable%2C%20with%20151%20different%20drug%20combinations.%20Among%20the%20156%5C%2F188%20%2883%5Cu00b70%25%29%20patients%20with%20available%20treatment%20outcomes%2C%20the%20pooled%20percentage%20of%20successful%20outcomes%20was%2040%5Cu00b72%25%20%2895%25%20confidence%20interval%20%5B95%25%20CI%5D%2028%5Cu00b74%25-53%5Cu00b72%25%29.%20In%20patients%20with%20unsuccessful%20treatment%20outcomes%20%28101%5C%2F156%29%2C%20most%20experienced%20treatment%20failure%20%28n%20%3D%2057%5C%2F156%20%5Bpooled%20proportion%2037%5Cu00b71%25%5D%2C%2095%25%20CI%3A%2026%5Cu00b71%25-49%5Cu00b77%25%29%20or%20death%20%28n%20%3D%2030%5C%2F156%20%5Bpooled%20proportion%2021%5Cu00b73%25%5D%2C%2095%25%20CI%3A%2015%5Cu00b77%25-28%5Cu00b72%25%29.%20After%20adjustment%20for%20disease%20severity%2C%20each%20additional%20likely%20effective%20drug%20decreased%20the%20odds%20of%20unsuccessful%20outcomes%20%28adjusted%20odds%20ratio%3A%200%5Cu00b765%2C%2095%25%20CI%3A%200%5Cu00b745-0%5Cu00b796%29%20%28p%20%3D%200%5Cu00b7026%29%2C%20whereas%20being%20treated%20in%20an%20upper-middle-income%20country%20increased%20the%20odds%20of%20unsuccessful%20outcomes%20compared%20with%20being%20treated%20in%20a%20high-income%20country%20%28adjusted%20odds%20ratio%3A%2013%5Cu00b77%2C%2095%25%20CI%3A%203%5Cu00b77-50%5Cu00b72%29%20%28p%20%26lt%3B%200%5Cu00b7001%29.%20Compared%20with%20other%20levels%20of%20drug%20resistance%2C%20treatment%20outcomes%20were%20significantly%20worse%20for%20extensively%20drug-resistant%20tuberculosis.%5CnINTERPRETATION%3A%20Only%20four%20out%20of%20ten%20patients%20affected%20by%20extensively%20drug-resistant%20tuberculosis%20achieved%20successful%20treatment%20outcomes.%20These%20findings%20highlight%20the%20need%20for%20adequate%2C%20individualised%20treatment%20regimens%20and%20optimised%20drug%20susceptibility%20testing.%5CnFUNDING%3A%20None.%22%2C%22date%22%3A%222025-09%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.lanepe.2025.101380%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%222666-7762%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-08-21T13%3A36%3A00Z%22%7D%7D%2C%7B%22key%22%3A%22BY43HBWY%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kuksa%20et%20al.%22%2C%22parsedDate%22%3A%222025-03-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKuksa%2C%20L.%2C%20Andrejak%2C%20C.%2C%20Haecker%2C%20B.%2C%20Bothamley%2C%20G.%2C%20Calcagno%2C%20A.%2C%20Cirillo%2C%20D.%20M.%2C%20Duarte%2C%20R.%2C%20Fatima%2C%20R.%2C%20Ferlazzo%2C%20G.%2C%20Guglielmetti%2C%20L.%2C%20G%26%23xFC%3Bnther%2C%20G.%2C%20Hewison%2C%20C.%2C%20Horsburgh%2C%20C.%20R.%2C%20J%26%23xE4%3Bger%2C%20T.%2C%20Kalancha%2C%20Y.%2C%20Otto-Knapp%2C%20R.%2C%20Kranzer%2C%20K.%2C%20Lillebaek%2C%20T.%2C%20Marks%2C%20G.%2C%20Middelkoop%2C%20K.%2C%20Motta%2C%20I.%2C%20Rabinova%2C%20V.%2C%20Sommerfeld%2C%20P.%2C%20Tattevin%2C%20P.%20and%20Lange%2C%20C.%20%282025%29.%20%26lt%3Bb%26gt%3BUrgent%20request%20for%20pretomanid%20label%20expansion%20to%20align%20with%20WHO%20guidelines%20and%20improve%20treatment%20accessibility%20and%20efficacy%26lt%3B%5C%2Fb%26gt%3B.%20IJTLD%20OPEN%20%26lt%3Bi%26gt%3B2%26lt%3B%5C%2Fi%26gt%3B%2C%20117%26%23x2013%3B119%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.5588%5C%2Fijtldopen.25.0152%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.5588%5C%2Fijtldopen.25.0152%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Urgent%20request%20for%20pretomanid%20label%20expansion%20to%20align%20with%20WHO%20guidelines%20and%20improve%20treatment%20accessibility%20and%20efficacy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Kuksa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Andrejak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Haecker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22Bothamley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Calcagno%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.M.%22%2C%22lastName%22%3A%22Cirillo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Duarte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Fatima%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22Ferlazzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22G%5Cu00fcnther%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Hewison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.R.%22%2C%22lastName%22%3A%22Horsburgh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%22%2C%22lastName%22%3A%22J%5Cu00e4ger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Y.%22%2C%22lastName%22%3A%22Kalancha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Otto-Knapp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Kranzer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%22%2C%22lastName%22%3A%22Lillebaek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22Marks%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Middelkoop%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22I.%22%2C%22lastName%22%3A%22Motta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Rabinova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Sommerfeld%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Tattevin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Lange%22%7D%5D%2C%22abstractNote%22%3A%22Pretomanid%20is%20a%20key%20anti-TB%20drug%20included%20in%20the%20WHO%20list%20of%20essential%20medications.%20The%20current%20EMA-approved%20label%20for%20pretomanid%20restricts%20its%20use%20to%20the%20regimen%20comprising%20bedaquiline%2C%20pretomanid%20and%20linezolid%20%28BPaL%29%20and%20only%20for%20extensively%20drug-resistant-TB%20or%20multidrug-resistant%20%5Cn%20TB%2C%20%5Cu201cwhen%20antibiotics%20used%20for%20the%20latter%20form%20of%20TB%20do%20not%20work%20or%20cause%20unacceptable%20side%20effects.%5Cu201d%20This%20restricted%20use%20implies%20that%20the%20older%2C%20prolonged%20and%20poorly%20tolerated%20regimens%20remain%20the%20recommended%20treatment%20for%20most%20cases%20of%20drug-resistant%20TB.%20The%20authors%2C%20representing%20%5Cn%20many%20respiratory%20groups%20and%20societies%2C%20call%20for%20the%20label%20expansion%20of%20pretomanid%20to%20align%20with%20global%20guidelines%2C%20allowing%20for%20broader%20use.%22%2C%22date%22%3A%222025-03-01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.5588%5C%2Fijtldopen.25.0152%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ingentaconnect.com%5C%2Fcontent%5C%2F10.5588%5C%2Fijtldopen.25.0152%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%223005-7590%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-05-09T13%3A31%3A04Z%22%7D%7D%2C%7B%22key%22%3A%22M5HX4KAL%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lange%20et%20al.%22%2C%22parsedDate%22%3A%222025-03-02%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLange%2C%20C.%2C%20Bothamley%2C%20G.%2C%20G%26%23xFC%3Bnther%2C%20G.%2C%20Guglielmetti%2C%20L.%2C%20Kontsevaya%2C%20I.%2C%20Kuksa%2C%20L.%2C%20Lange%2C%20B.%2C%20Lorent%2C%20N.%2C%20Saluzzo%2C%20F.%2C%20Sester%2C%20M.%2C%20Tebruegge%2C%20M.%2C%20Tunesi%2C%20S.%20and%20Tweed%2C%20C.%20%282025%29.%20%26lt%3Bb%26gt%3BA%20Year%20in%20Review%20on%20Tuberculosis%20and%20Non-tuberculous%20Mycobacteria%20Disease%3A%20A%202025%20Update%20for%20Clinicians%20and%20Scientists%26lt%3B%5C%2Fb%26gt%3B.%20PAI%20%26lt%3Bi%26gt%3B10%26lt%3B%5C%2Fi%26gt%3B%2C%201%26%23x2013%3B45%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.20411%5C%2Fpai.v10i2.791%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.20411%5C%2Fpai.v10i2.791%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20Year%20in%20Review%20on%20Tuberculosis%20and%20Non-tuberculous%20Mycobacteria%20Disease%3A%20A%202025%20Update%20for%20Clinicians%20and%20Scientists%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christoph%22%2C%22lastName%22%3A%22Lange%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Graham%22%2C%22lastName%22%3A%22Bothamley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gunar%22%2C%22lastName%22%3A%22G%5Cu00fcnther%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Irina%22%2C%22lastName%22%3A%22Kontsevaya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liga%22%2C%22lastName%22%3A%22Kuksa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Berit%22%2C%22lastName%22%3A%22Lange%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natalie%22%2C%22lastName%22%3A%22Lorent%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francesca%22%2C%22lastName%22%3A%22Saluzzo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martina%22%2C%22lastName%22%3A%22Sester%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc%22%2C%22lastName%22%3A%22Tebruegge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simone%22%2C%22lastName%22%3A%22Tunesi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Conor%22%2C%22lastName%22%3A%22Tweed%22%7D%5D%2C%22abstractNote%22%3A%22Background%3A%20In%20the%20field%20of%20tuberculosis%20and%20non-tuberculous%20mycobacterial%20%28NTM%29%20disease%20we%20are%20looking%20back%20on%20an%20exciting%20year%202024%20with%20more%20than%2010%2C000%20publications%20listed%20in%20PubMed.%20%5CnMethods%3A%20Our%20aim%2C%20to%20review%20the%20scientific%20literature%20of%20the%20year%202024%2C%20is%20challenged%20by%20the%20enormous%20number%20of%20publications.%20Therefore%2C%20if%20your%20article%20is%20not%20included%20or%20your%20favorite%20field%20of%20mycobacteriology%20not%20covered%2C%20please%20forgive%20us.%20Our%20%5Cu201cYear%20in%20Review%5Cu201d%20is%20very%20much%20clinically%20oriented%20with%20lesser%20emphasis%20on%20basic%20science%2C%20microbiology%2C%20and%20biotechnology.%20%5CnResults%3A%20Members%20of%20the%20steering%20committee%20of%20the%20Tuberculosis%20Network%20European%20Trials%20group%20%28TBnet%3B%20www.tbnet.eu%29%20report%20on%20139%20publications%20in%20the%20fields%20of%20epidemiology%2C%20prevention%2C%20diagnosis%2C%20and%20treatment%20of%20tuberculosis%20and%20NTM%20diseases%20published%20in%202024%20that%20we%20found%20particularly%20important.%20We%20report%20publications%20separately%20for%20tuberculosis%20in%20children%20and%20adults%20and%20for%20NTM%20disease%20and%20provide%20a%20brief%20overview%20of%20newer%20technologies%20in%20the%20diagnostic%20pipeline.%20Furthermore%2C%20we%20summarize%20priorities%20for%20tuberculosis%20and%20NTM%20disease%20research%2C%20development%2C%20and%20implementation%2C%20all%20of%20which%20represent%20the%20perspective%20of%20our%20combined%20clinical%20experience.%20%5CnConclusions%3A%20This%20Year%20in%20Review%20provides%20a%20concise%20summary%20of%20the%20clinically%20relevant%20highlights%20of%20the%20published%20literature%20in%20tuberculosis%20and%20NTM%20diseases%20in%202024.%22%2C%22date%22%3A%222025-03-02%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.20411%5C%2Fpai.v10i2.791%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.paijournal.com%5C%2Findex.php%5C%2Fpaijournal%5C%2Farticle%5C%2Fview%5C%2F791%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%222469-2964%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-05-09T13%3A30%3A56Z%22%7D%7D%2C%7B%22key%22%3A%22MP73UHH5%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22M%5Cu00e9cha%5Cu00ef%20et%20al.%22%2C%22parsedDate%22%3A%222025%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BM%26%23xE9%3Bcha%26%23xEF%3B%2C%20F.%2C%20Beugre%2C%20E.%2C%20Billard-Pomares%2C%20T.%2C%20Mougari%2C%20F.%2C%20Wyplosz%2C%20B.%2C%20Cambau%2C%20E.%20and%20Vignier%2C%20N.%20%282025%29.%20%26lt%3Bb%26gt%3BUsefulness%20of%20the%20GeneXpert%20MTB%5C%2FRIF%20Ct%20for%20predicting%20tuberculosis%20infectiousness%26lt%3B%5C%2Fb%26gt%3B.%20Infectious%20Diseases%20Now%20%26lt%3Bi%26gt%3B55%26lt%3B%5C%2Fi%26gt%3B%2C%20105061%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.idnow.2025.105061%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.idnow.2025.105061%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Usefulness%20of%20the%20GeneXpert%20MTB%5C%2FRIF%20Ct%20for%20predicting%20tuberculosis%20infectiousness%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22M%5Cu00e9cha%5Cu00ef%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Beugre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%22%2C%22lastName%22%3A%22Billard-Pomares%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Mougari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Wyplosz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Vignier%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2206%5C%2F2025%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.idnow.2025.105061%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS2666991925000405%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%2226669919%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-12-26T10%3A44%3A52Z%22%7D%7D%2C%7B%22key%22%3A%22WTTLP6PD%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Sadowski%20et%20al.%22%2C%22parsedDate%22%3A%222025-04-11%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BSadowski%2C%20E.%2C%20Pietrancosta%2C%20N.%2C%20Veyron-Churlet%2C%20R.%2C%20Boucher%2C%20J.-L.%2C%20Pionneau%2C%20C.%2C%20Clodic%2C%20G.%2C%20Matheron%2C%20L.%2C%20Poch%2C%20O.%2C%20Mayer%2C%20C.%2C%20Sachon%2C%20E.%20and%20Aubry%2C%20A.%20%282025%29.%20%26lt%3Bb%26gt%3BCharacterization%20of%20the%20Orphan%20Cytochrome%20P450%20CYP135B1%20from%20%26lt%3Bi%26gt%3BMycobacterium%20tuberculosis%26lt%3B%5C%2Fi%26gt%3B%26%23x202F%3B%3A%20Involvement%20in%20Metabolism%20but%20Not%20in%20the%20Antibacterial%20Activity%20of%20the%20Antitubercular%20Drug%20SQ109%26lt%3B%5C%2Fb%26gt%3B.%20ACS%20Infect%20Dis%20%26lt%3Bi%26gt%3B11%26lt%3B%5C%2Fi%26gt%3B%2C%20869%26%23x2013%3B881%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1021%5C%2Facsinfecdis.4c00893%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1021%5C%2Facsinfecdis.4c00893%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Characterization%20of%20the%20Orphan%20Cytochrome%20P450%20CYP135B1%20from%20%3Ci%3EMycobacterium%20tuberculosis%3C%5C%2Fi%3E%20%3A%20Involvement%20in%20Metabolism%20but%20Not%20in%20the%20Antibacterial%20Activity%20of%20the%20Antitubercular%20Drug%20SQ109%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elodie%22%2C%22lastName%22%3A%22Sadowski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Pietrancosta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Romain%22%2C%22lastName%22%3A%22Veyron-Churlet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Luc%22%2C%22lastName%22%3A%22Boucher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%5Cu00e9dric%22%2C%22lastName%22%3A%22Pionneau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gilles%22%2C%22lastName%22%3A%22Clodic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucr%5Cu00e8ce%22%2C%22lastName%22%3A%22Matheron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olivier%22%2C%22lastName%22%3A%22Poch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudine%22%2C%22lastName%22%3A%22Mayer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Sachon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222025-04-11%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1021%5C%2Facsinfecdis.4c00893%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fpubs.acs.org%5C%2Fdoi%5C%2F10.1021%5C%2Facsinfecdis.4c00893%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%222373-8227%2C%202373-8227%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-05-09T12%3A38%3A34Z%22%7D%7D%2C%7B%22key%22%3A%22UG42N69S%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Seddon%20et%20al.%22%2C%22parsedDate%22%3A%222025-06-06%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BSeddon%2C%20J.%20A.%2C%20Achar%2C%20J.%2C%20Malik%2C%20A.%20A.%2C%20Hughes%2C%20J.%2C%20Burzynski%2C%20J.%2C%20Chen%2C%20C.%2C%20Denholm%2C%20J.%20T.%2C%20Dravniece%2C%20G.%2C%20Fox%2C%20G.%20J.%2C%20Furin%2C%20J.%2C%20Geliukh%2C%20E.%2C%20Goncharova%2C%20O.%2C%20Guglielmetti%2C%20L.%2C%20Harries%2C%20A.%20D.%2C%20Hesseling%2C%20A.%20C.%2C%20Nguyen%2C%20B.%20H.%2C%20Kavenga%2C%20F.%2C%20Khan%2C%20U.%2C%20Kherabi%2C%20Y.%2C%20Kiria%2C%20N.%2C%20Kock%2C%20Y.%2C%20Liu%2C%20Q.%2C%20Mesic%2C%20A.%2C%20Moore%2C%20D.%20A.%20J.%2C%20Mubanga%2C%20A.%2C%20Naidoo%2C%20L.%2C%20Nilsen%2C%20D.%2C%20Piubello%2C%20A.%2C%20Reuter%2C%20A.%2C%20Rich%2C%20M.%20L.%2C%20Satyanarayana%2C%20S.%2C%20Schaaf%2C%20H.%20S.%2C%20Schoeman%2C%20I.%2C%20Skrahina%2C%20A.%2C%20Udwadia%2C%20Z.%2C%20Khan%2C%20P.%20Y.%2C%20Esmail%2C%20H.%20and%20Martinez%2C%20L.%20%282025%29.%20%26lt%3Bb%26gt%3BManagement%20of%20individuals%20exposed%20to%20multidrug-resistant%20or%20rifampicin-resistant%20tuberculosis%26lt%3B%5C%2Fb%26gt%3B.%20The%20Lancet%20Infectious%20Diseases%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS1473-3099%2825%2900157-4%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS1473-3099%2825%2900157-4%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Management%20of%20individuals%20exposed%20to%20multidrug-resistant%20or%20rifampicin-resistant%20tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20A%22%2C%22lastName%22%3A%22Seddon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jay%22%2C%22lastName%22%3A%22Achar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amyn%20A%22%2C%22lastName%22%3A%22Malik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%22%2C%22lastName%22%3A%22Hughes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%22%2C%22lastName%22%3A%22Burzynski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cheng%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Justin%20T%22%2C%22lastName%22%3A%22Denholm%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gunta%22%2C%22lastName%22%3A%22Dravniece%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Greg%20J%22%2C%22lastName%22%3A%22Fox%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%22%2C%22lastName%22%3A%22Furin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Evgenia%22%2C%22lastName%22%3A%22Geliukh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olga%22%2C%22lastName%22%3A%22Goncharova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anthony%20D%22%2C%22lastName%22%3A%22Harries%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anneke%20C%22%2C%22lastName%22%3A%22Hesseling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Binh%20Hoa%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fungai%22%2C%22lastName%22%3A%22Kavenga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Uzma%22%2C%22lastName%22%3A%22Khan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yousra%22%2C%22lastName%22%3A%22Kherabi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nana%22%2C%22lastName%22%3A%22Kiria%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yulene%22%2C%22lastName%22%3A%22Kock%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qiao%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anita%22%2C%22lastName%22%3A%22Mesic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20A%20J%22%2C%22lastName%22%3A%22Moore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angel%22%2C%22lastName%22%3A%22Mubanga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lenny%22%2C%22lastName%22%3A%22Naidoo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Diana%22%2C%22lastName%22%3A%22Nilsen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alberto%22%2C%22lastName%22%3A%22Piubello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anja%22%2C%22lastName%22%3A%22Reuter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20L%22%2C%22lastName%22%3A%22Rich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Srinath%22%2C%22lastName%22%3A%22Satyanarayana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H%20Simon%22%2C%22lastName%22%3A%22Schaaf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ingrid%22%2C%22lastName%22%3A%22Schoeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alena%22%2C%22lastName%22%3A%22Skrahina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zarir%22%2C%22lastName%22%3A%22Udwadia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Palwasha%20Y%22%2C%22lastName%22%3A%22Khan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hanif%22%2C%22lastName%22%3A%22Esmail%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leonardo%22%2C%22lastName%22%3A%22Martinez%22%7D%5D%2C%22abstractNote%22%3A%22Individuals%20exposed%20to%20a%20person%20with%20infectious%20multidrug-resistant%20or%20rifampicin-resistant%20%28MDR-RR%29%20tuberculosis%20are%20at%20risk%20of%20developing%20tuberculosis%20disease.%20Historically%2C%20insufficient%20empirical%20evidence%20for%20preventive%20treatment%20in%20this%20group%20has%20permitted%20inadequate%20guidance%20for%20clinical%20decision%20making.%20However%2C%20several%20high-quality%20studies%20have%20been%20published%20detailing%20preventive%20treatment%20options%20for%20these%20contacts%20at%20high%20risk.%20In%20this%20Review%2C%20we%20discuss%20the%20management%20of%20individuals%20exposed%20to%20patients%20with%20infectious%20MDR-RR%20tuberculosis.%20We%20pay%20particular%20attention%20to%20the%20entire%20spectrum%20of%20clinical%20care%20for%20this%20population%2C%20including%20baseline%20assessment%2C%20possible%20preventive%20treatments%2C%20follow-up%2C%20and%20shared%20decision%20making.%20We%20discuss%20the%20available%20evidence%2C%20the%20rationales%20for%20different%20management%20strategies%2C%20and%20the%20interactions%20with%20%28and%20implications%20of%29%20secondary%20comorbidities%20such%20as%20HIV%20or%20malnutrition.%22%2C%22date%22%3A%222025-06-06%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2FS1473-3099%2825%2900157-4%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS1473309925001574%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221473-3099%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-08-21T13%3A31%3A56Z%22%7D%7D%2C%7B%22key%22%3A%22348MPEYW%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Serge%20Diagbouga%20et%20al.%22%2C%22parsedDate%22%3A%222025-06-11%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BSerge%20Diagbouga%2C%20P.%2C%20Djibougou%2C%20A.%20D.%2C%20Pease%2C%20C.%2C%20Alcaide%2C%20A.%2C%20Berthoux%2C%20A.%2C%20Bruiners%2C%20N.%2C%20Cirillo%2C%20D.%20M.%2C%20Combary%2C%20A.%2C%20Falchero%2C%20N.%2C%20Handler%2C%20D.%2C%20Kabor%26%23xE9%3B%2C%20A.%2C%20Lardizabal%2C%20A.%2C%20Lopes%2C%20A.%2C%20Loubet%2C%20M.%2C%20Manivet%2C%20P.%2C%20Margain%2C%20C.%2C%20Meunier%2C%20V.%2C%20Mougari%2C%20F.%2C%20Onyuka%2C%20A.%2C%20Rivoiron%2C%20S.%2C%20Sagna%2C%20T.%2C%20Sanvert%2C%20M.%2C%20Sawadogo%2C%20L.%2C%20Simpor%26%23xE9%3B%2C%20J.%2C%20Cambau%2C%20E.%20and%20Gennaro%2C%20M.%20L.%20%282025%29.%20%26lt%3Bb%26gt%3BPreliminary%20performance%20of%20the%20VIDAS%20TB-IGRA%20as%20an%20aid%20in%20the%20diagnosis%20of%20individuals%20infected%20with%20%26lt%3Bi%26gt%3BMycobacterium%20tuberculosis%26lt%3B%5C%2Fi%26gt%3B%26lt%3B%5C%2Fb%26gt%3B%20Ed.%20Miller%2C%20M.%20B.%20J%20Clin%20Microbiol%20%26lt%3Bi%26gt%3B63%26lt%3B%5C%2Fi%26gt%3B%2C%20e01641-24%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2Fjcm.01641-24%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2Fjcm.01641-24%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Preliminary%20performance%20of%20the%20VIDAS%20TB-IGRA%20as%20an%20aid%20in%20the%20diagnosis%20of%20individuals%20infected%20with%20%3Ci%3EMycobacterium%20tuberculosis%3C%5C%2Fi%3E%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Potiandi%22%2C%22lastName%22%3A%22Serge%20Diagbouga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arthur%20Diakourga%22%2C%22lastName%22%3A%22Djibougou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Camille%22%2C%22lastName%22%3A%22Pease%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ariana%22%2C%22lastName%22%3A%22Alcaide%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Audrey%22%2C%22lastName%22%3A%22Berthoux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natalie%22%2C%22lastName%22%3A%22Bruiners%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniela%20Maria%22%2C%22lastName%22%3A%22Cirillo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ardjouma%22%2C%22lastName%22%3A%22Combary%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nadine%22%2C%22lastName%22%3A%22Falchero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deborah%22%2C%22lastName%22%3A%22Handler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoinette%22%2C%22lastName%22%3A%22Kabor%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alfred%22%2C%22lastName%22%3A%22Lardizabal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amanda%22%2C%22lastName%22%3A%22Lopes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marissa%22%2C%22lastName%22%3A%22Loubet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philippe%22%2C%22lastName%22%3A%22Manivet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clemence%22%2C%22lastName%22%3A%22Margain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valerie%22%2C%22lastName%22%3A%22Meunier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faiza%22%2C%22lastName%22%3A%22Mougari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alberta%22%2C%22lastName%22%3A%22Onyuka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sophie%22%2C%22lastName%22%3A%22Rivoiron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tani%22%2C%22lastName%22%3A%22Sagna%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mathilde%22%2C%22lastName%22%3A%22Sanvert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L%5Cu00e9on%22%2C%22lastName%22%3A%22Sawadogo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacques%22%2C%22lastName%22%3A%22Simpor%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%20Laura%22%2C%22lastName%22%3A%22Gennaro%22%7D%2C%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22Melissa%20B.%22%2C%22lastName%22%3A%22Miller%22%7D%5D%2C%22abstractNote%22%3A%22ABSTRACT%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20This%20preliminary%20study%20compares%20VIDAS%20TB-IGRA%20%28bioM%5Cu00e9rieux%2C%20Marcy-l%26%23039%3BEtoile%2C%20France%29%20with%20the%20established%20QuantiFERON-TB%20Gold%20Plus%20%28QFT-Plus%29%20%28Qiagen%2C%20Hilden%2C%20Germany%29%20to%20evaluate%20diagnostic%20performance%20for%20the%20diagnosis%20of%20individuals%20infected%20with%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20Mycobacterium%20tuberculosis%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20complex%20%28latent%20infection%20and%20disease%29.%20The%20study%20was%20multi-center%20and%20performed%20between%202%20October%202019%20and%204%20February%202020.%20Participants%20were%20divided%20into%20tuberculosis%20%28TB%29%20disease%2C%20high-risk%2C%20and%20low-risk%20populations.%20The%20confirmed%20TB%20disease%20population%20included%20104%20patients.%20The%20high-risk%20population%20included%20162%20individuals%20with%20flagged%20risk%20factors%20on%20a%20questionnaire%20but%20without%20objective%20clinical%20confirmation%20of%20TB.%20The%20low-risk%20population%20included%20117%20healthy%20blood%20donors%20from%20the%20French%20National%20Blood%20Bank.%20Positive%20and%20negative%20percent%20agreement%20%28PPA%20and%20NPA%29%20were%20determined%20between%20the%20VIDAS%20TB-IGRA%20and%20QFT-Plus.%20In%20the%20TB%20disease%20population%2C%20sensitivity%20was%20measured%20against%20bacterial%20culture%20and%20PCR.%20The%20VIDAS%20TB-IGRA%20produced%20fewer%20indeterminate%20results%20than%20the%20QFT-Plus%20%281%5C%2F104%20vs%2023%5C%2F104%29%20in%20the%20TB%20disease%20population%20and%20exhibited%20a%20sensitivity%20of%2095.0%25%20against%20bacterial%20culture.%20Furthermore%2C%20a%2098.2%25%20PPA%20was%20obtained%20in%20comparison%20to%20QFT-Plus.%20In%20the%20low-risk%20population%2C%20the%20VIDAS%20TB-IGRA%20demonstrated%20high%20specificity%20%2894.9%25%29%20and%20a%20strong%20NPA%20%2898.2%25%29%20compared%20to%20QFT-Plus.%20In%20the%20high-risk%20population%2C%20the%20VIDAS%20TB-IGRA%20exhibited%20a%20strong%20PPA%20%2894.4%25%29%20with%20the%20QFT-Plus.%20A%20lower%20NPA%20was%20observed%20%2885.2%25%29%20compared%20to%20QFT-Plus%2C%20which%20may%20be%20due%20to%20a%20higher%20sensitivity%20demonstrated%20in%20the%20TB%20disease%20population.%20The%20fully%20automated%20VIDAS%20TB-IGRA%20is%20a%20promising%20aid%20in%20the%20diagnosis%20of%20individuals%20infected%20with%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20Mycobacterium%20tuberculosis%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%28latent%20infection%20and%20active%20disease%29.%20It%20exhibits%20higher%20sensitivity%20while%20maintaining%20specificity%20and%20produces%20fewer%20indeterminate%20interpretations%20than%20QFT-Plus.%20Its%20easy-to-use%2C%20single-patient%20format%20may%20lead%20to%20increased%20TB%20testing%20to%20aid%20in%20the%20adequate%20diagnosis%20and%20management%20of%20the%20disease.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20IMPORTANCE%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20This%20study%20presents%20a%20comprehensive%20evaluation%20of%20the%20VIDAS%20TB-IGRA%20diagnostic%20test.%20This%20test%20is%20compared%20with%20the%20established%20QuantiFERON-TB%20Gold%20Plus%20to%20assess%20its%20effectiveness%20in%20diagnosing%20both%20latent%20and%20active%20tuberculosis%20%28TB%29%20infections.%20The%20study%20highlights%20the%20VIDAS%20TB-IGRA%5Cu2019s%20higher%20sensitivity%2C%20fewer%20indeterminate%20results%2C%20and%20robust%20performance%20across%20different%20patient%20populations%2C%20including%20those%20with%20confirmed%20TB%20disease%2C%20high-risk%2C%20and%20low-risk%20groups.%20The%20findings%20suggest%20that%20the%20VIDAS%20TB-IGRA%20could%20enhance%20TB%20diagnosis%20and%20management%2C%20offering%20a%20fully%20automated%2C%20easy-to-use%20solution%20that%20reduces%20human%20error%20and%20result%20variability.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%2C%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20This%20study%20presents%20a%20comprehensive%20evaluation%20of%20the%20VIDAS%20TB-IGRA%20diagnostic%20test.%20This%20test%20is%20compared%20with%20the%20established%20QuantiFERON-TB%20Gold%20Plus%20to%20assess%20its%20effectiveness%20in%20diagnosing%20both%20latent%20and%20active%20tuberculosis%20%28TB%29%20infections.%20The%20study%20highlights%20the%20VIDAS%20TB-IGRA%5Cu2019s%20higher%20sensitivity%2C%20fewer%20indeterminate%20results%2C%20and%20robust%20performance%20across%20different%20patient%20populations%2C%20including%20those%20with%20confirmed%20TB%20disease%2C%20high-risk%2C%20and%20low-risk%20groups.%20The%20findings%20suggest%20that%20the%20VIDAS%20TB-IGRA%20could%20enhance%20TB%20diagnosis%20and%20management%2C%20offering%20a%20fully%20automated%2C%20easy-to-use%20solution%20that%20reduces%20human%20error%20and%20result%20variability.%22%2C%22date%22%3A%222025-06-11%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1128%5C%2Fjcm.01641-24%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fjournals.asm.org%5C%2Fdoi%5C%2F10.1128%5C%2Fjcm.01641-24%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220095-1137%2C%201098-660X%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-09-30T15%3A02%3A41Z%22%7D%7D%2C%7B%22key%22%3A%22GYDNQB7I%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Soutou%20et%20al.%22%2C%22parsedDate%22%3A%222025%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BSoutou%2C%20M.%20A.%2C%20Allam%2C%20C.%2C%20Abi%20Fadel%2C%20M.%2C%20Najjar%2C%20J.%2C%20Guyeux%2C%20C.%2C%20Cambau%2C%20E.%20and%20Sola%2C%20C.%20%282025%29.%20%26lt%3Bb%26gt%3BAn%20insight%20into%20the%20characterization%20of%20L2%20Beijing%20multi-drug%20resistant%20tuberculosis%3A%20Description%20of%20resistance-associated-variants%20and%20discovery%20of%20Modern%207%20L2%20sublineage%26lt%3B%5C%2Fb%26gt%3B.%20Infection%2C%20Genetics%20and%20Evolution%20%26lt%3Bi%26gt%3B134%26lt%3B%5C%2Fi%26gt%3B%2C%20105797%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.meegid.2025.105797%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.meegid.2025.105797%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22An%20insight%20into%20the%20characterization%20of%20L2%20Beijing%20multi-drug%20resistant%20tuberculosis%3A%20Description%20of%20resistance-associated-variants%20and%20discovery%20of%20Modern%207%20L2%20sublineage%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marianne%20Antar%22%2C%22lastName%22%3A%22Soutou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Camille%22%2C%22lastName%22%3A%22Allam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marianne%22%2C%22lastName%22%3A%22Abi%20Fadel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Josette%22%2C%22lastName%22%3A%22Najjar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christophe%22%2C%22lastName%22%3A%22Guyeux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christophe%22%2C%22lastName%22%3A%22Sola%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2210%5C%2F2025%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.meegid.2025.105797%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS1567134825000863%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%2215671348%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-09-30T14%3A59%3A12Z%22%7D%7D%2C%7B%22key%22%3A%22QG4CZPV6%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Verma%20et%20al.%22%2C%22parsedDate%22%3A%222025-04-02%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BVerma%2C%20A.%20K.%2C%20Kim%2C%20R.%20Q.%2C%20Lamprecht%2C%20D.%20A.%2C%20Aguilar-P%26%23xE9%3Brez%2C%20C.%2C%20Wong%2C%20S.%2C%20Veziris%2C%20N.%2C%20Aubry%2C%20A.%2C%20Bartolom%26%23xE9%3B-Nebreda%2C%20J.%20M.%2C%20Carbajo%2C%20R.%20J.%2C%20Wetzel%2C%20J.%20and%20Lamers%2C%20M.%20H.%20%282025%29.%20%26lt%3Bb%26gt%3BStructural%20and%20mechanistic%20study%20of%20a%20novel%20inhibitor%20analogue%20of%20M.%20tuberculosis%20cytochrome%20bc1%3Aaa3%26lt%3B%5C%2Fb%26gt%3B.%20npj%20Drug%20Discov%20%26lt%3Bi%26gt%3B2%26lt%3B%5C%2Fi%26gt%3B%2C%206%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs44386-025-00008-3%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs44386-025-00008-3%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Structural%20and%20mechanistic%20study%20of%20a%20novel%20inhibitor%20analogue%20of%20M.%20tuberculosis%20cytochrome%20bc1%3Aaa3%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amit%20K.%22%2C%22lastName%22%3A%22Verma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robbert%20Q.%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dirk%20A.%22%2C%22lastName%22%3A%22Lamprecht%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clara%22%2C%22lastName%22%3A%22Aguilar-P%5Cu00e9rez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Wong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jos%5Cu00e9%20M.%22%2C%22lastName%22%3A%22Bartolom%5Cu00e9-Nebreda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rodrigo%20J.%22%2C%22lastName%22%3A%22Carbajo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennefer%22%2C%22lastName%22%3A%22Wetzel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meindert%20H.%22%2C%22lastName%22%3A%22Lamers%22%7D%5D%2C%22abstractNote%22%3A%22Abstract%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Drug-resistant%20tuberculosis%20%28TB%29%20continues%20to%20challenge%20treatment%20options%2C%20necessitating%20the%20exploration%20of%20new%20compounds%20of%20novel%20targets.%20The%20mycobacterial%20respiratory%20complex%20cytochrome%20bc%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%201%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%3Aaa%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%203%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20has%20emerged%20as%20a%20promising%20target%2C%20exemplified%20by%20the%20success%20of%20first-in-class%20inhibitor%20Q203%20in%20phase%202%20clinical%20trials.%20However%2C%20to%20fully%20exploit%20the%20potential%20of%20this%20target%20and%20to%20identify%20the%20best-in-class%20inhibitor%20more%20compounds%20need%20evaluation.%20Here%2C%20we%20introduce%20JNJ-2901%2C%20a%20novel%20Q203%20analogue%2C%20that%20demonstrates%20activity%20against%20multidrug-resistant%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20M.%20tuberculosis%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20clinical%20strains%20at%20sub-nanomolar%20concentration%20and%204-log%20reduction%20in%20bacterial%20burden%20in%20a%20mouse%20model%20of%20TB%20infection.%20Inhibitory%20studies%20on%20purified%20enzymes%20validate%20the%20nanomolar%20inhibitions%20observed%20in%20mycobacterial%20cells.%20Additionally%2C%20cryo-EM%20structure%20analysis%20of%20cytochrome%20bc%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%201%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%3Aaa%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%203%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20bound%20to%20JNJ-2901%20reveals%20the%20binding%20pocket%20at%20the%20menaquinol%20oxidation%20site%20%28Qp%29%2C%20akin%20to%20other%20substate%20analogue%20inhibitors%20like%20Q203%20and%20TB47.%20Validation%20of%20the%20binding%20site%20is%20further%20achieved%20by%20generating%20and%20isolating%20the%20JNJ-2901%20resistant%20mutations%20in%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20M.%20tuberculosis%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%2C%20followed%20by%20purification%20and%20resistance%20analysis%20of%20the%20resistant%20cytochrome%20bc%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%201%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%3Aaa%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%203%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20complex.%20Our%20comprehensive%20work%20lays%20the%20foundation%20for%20further%20clinical%20validations%20of%20JNJ-2901.%22%2C%22date%22%3A%222025-04-02%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1038%5C%2Fs44386-025-00008-3%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs44386-025-00008-3%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%223005-1452%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222025-05-09T12%3A36%3A50Z%22%7D%7D%5D%7D
Aguilar-Pérez, C., Lenaerts, A. J., Villellas, C., Guillemont, J., Dallow, J., Painter, H., Ammerman, N. C., Hassan, A., Golovkine, G., Brock, L., Sordello, S., Chauffour, A., Aubry, A., Mai, T. C., Wong, S., Clark, T. G., Nam, K., Kim, J., Choi, J., Crabbe, M., Esquivias, J., Lounis, N., Stoops, B., Amssoms, K., Bartolome-Nebreda, J. M., Gruppo, V., Robertson, G. T., Veziris, N., Upton, A. M., Nuermberger, E. L., Cox, V., Ballell, L., Baeten, B., Koul, A., Pym, A. S., Wall, R. J. and Lamprecht, D. A. (2025). The role of cytochrome bc1 inhibitors in future tuberculosis treatment regimens. Nat Commun 16, 9344, http://doi.org/10.1038/s41467-025-64427-6.
Allam, C., Haenn, S., Giraud, E., Awad, Z., Robert, J., Cambau, E., Moulin, L. and Mougari, F. (2025). Standardised protocol for the detection and quantification of nontuberculous mycobacteria (NTM) in tap water and its application in investigating the source of NTM clinical infections. International Journal of Hygiene and Environmental Health 268, 114618, http://doi.org/10.1016/j.ijheh.2025.114618.
Benhard, J., Monsel, G., Dubée, V., Pavese, P., Rasoldier, V., Garrait, V., Talleux, M., Vuotto, F., Gueneau, R., Pouget-Abadie, X., Thy, M., Palacios, C., Bachir, M., Djossou, F., Tunesi, S., Jachym, M. F., Pourcher, V., Veziris, N. and Bourgarit, A. (2025). Standardized Infliximab Regimen to Treat Severe Central Nervous System Tuberculosis: A Case Series of 18 Patients. Open Forum Infectious Diseases 12, ofaf450, http://doi.org/10.1093/ofid/ofaf450.
Bonnet, I., Orgeur, M., Brossier, F., Sayes, F., Frigui, W., Madacki, J., Varet, H., Chauffour, A., Aubry, A., Veziris, N., Sougakoff, W., Brosch, R. and Tournebize, R. (2025). Evaluation of the role of whiB6 and kdpDE in the dominant multidrug-resistant clone Mycobacterium tuberculosis B0/W148 Ed. Doucet-Populaire, F. C. Microbiol Spectr e03224-24, http://doi.org/10.1128/spectrum.03224-24.
Chauffour, A., Cambau, E., Pethe, K., Veziris, N. and Aubry, A. (2025). Unprecedented in vivo activity of telacebec against Mycobacterium leprae Ed. Steinmann, P. PLoS Negl Trop Dis 19, e0013076, http://doi.org/10.1371/journal.pntd.0013076.
Fomba, A., Haidara, F. C., Kodio, M., Arama, C., Cambau, E., Chauffour, A., Veziris, N., Broeckling, B. E., Warren, A. K., Cauchoix, B., Alcaïs, A., Marsollier, L., Assé, H., Jackson, M., Sow, S. O., Faye, O., Jarlier, V., Cole, S. T., Avanzi, C., Aubry, A. and Johnson, R. C. (2025). Bedaquiline Activity against Leprosy. New England Journal of Medicine 392, 2174–2176, http://doi.org/10.1056/NEJMc2412487.
Fouchet, T., Nait Chabane, M., Allam, C., Awad, Z., Mougari, F., Hartmann, A., Rochelet, M. and Cambau, E. (2025). Clinical evaluation of the diagnostic performances and treatment monitoring of the new PATHFAST TB LAM Ag assay in sputum specimens of patients with tuberculosis or with nontuberculous mycobacteria pulmonary disease Ed. Miller, M. B. J Clin Microbiol 63, e01269-25, http://doi.org/10.1128/jcm.01269-25.
Gerussi, V., Petersen, T., Bonnet, I., Aubry, A., Bachir, M., Gyde, E., Morel, F., Poignon, C., Rached, B., Pourcher, V., Rioux, C., Vallois, D., Veziris, N., Robert, J. and Guglielmetti, L. (2025). Evaluation of High-Dose Isoniazid in Multidrug-Resistant Tuberculosis Treatment. Emerg Infect Dis 31, http://doi.org/10.3201/eid3103.241473.
Goletti, D., Banaei, N., Batra, R., Berger, A. E., Blazevic, A., Botelho-Nevers, E., Breen, R., Bruiners, N., Cambau, E., Carbonnelle, E., Daley, C. L., Descotes-Genon, C., Gennaro, F. D., Doucet-Populaire, F., Esmail, A., Guzman, J. D. E., Fontana, L., Gennaro, M. L., Handler, D., Torres, R. M. H., Hoft, D., Ismail, N., Isnard, M., Kenny, J., Lardizabal, A., Lesage, F. X., Lopes, A., Vidal, W. L. L., Contreras, R. M., Manivet, P., Marotte, H., Méchaï, F., Medjahed-Artebasse, A., Meldau, R., Mérieux, Y., Morel, J., Mougari, F., Oelofse, S., Palmieri, F., Perrot, J. L., Petruccioli, E., Pride, D. T., Tuaillon, E., Upton, C., Vanker, N. and Dheda, K. (2025). Accuracy of VIDAS® TB-IGRA in TB patients and individuals with different thresholds of exposure. International Journal of Infectious Diseases 108318, http://doi.org/10.1016/j.ijid.2025.108318.
Guglielmetti, L., Khan, U., Velásquez, G. E., Gouillou, M., Abubakirov, A., Baudin, E., Berikova, E., Berry, C., Bonnet, M., Cellamare, M., Chavan, V., Cox, V., Dakenova, Z., De Jong, B. C., Ferlazzo, G., Karabayev, A., Kirakosyan, O., Kiria, N., Kunda, M., Lachenal, N., Lecca, L., McIlleron, H., Motta, I., Toscano, S. M., Mushtaque, H., Nahid, P., Oyewusi, L., Panda, S., Patil, S., Phillips, P. P. J., Ruiz, J., Salahuddin, N., Garavito, E. S., Seung, K. J., Ticona, E., Trippa, L., Vasquez, D. E. V., Wasserman, S., Rich, M. L., Varaine, F. and Mitnick, C. D. (2025). Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis. N Engl J Med 392, 468–482, http://doi.org/10.1056/NEJMoa2400327.
Guglielmetti, L., Panda, S., Abubakirov, A., Salahuddin, N., Perrin, C. and Mitnick, C. D. (2025). Equitable, personalised medicine for tuberculosis: treating patients, not diseases. The Lancet Respiratory Medicine 13, 382–385, http://doi.org/10.1016/S2213-2600(25)00080-3.
Guglielmetti, L., Khan, U., Velásquez, G. E., Gouillou, M., Ali, M. H., Amjad, S., Kamal, F., Abubakirov, A., Ardizzoni, E., Baudin, E., Bektassov, S., Berry, C., Bonnet, M., Chavan, V., Coutisson, S., Dakenova, Z., de Jong, B. C., Dinh, L. V., Ferlazzo, G., Kirakosyan, O., Lachenal, N., Lecca, L., McIlleron, H., Mikanda, K. K., Mucching-Toscano, S., Mulders, W., Mushtaque, H., Nahid, P., Nguyen, D. V., Nguyen, N. V., Oyewusi, L., Motta, I., Panda, S., Patil, Sandip, Pham, T. H., Phan, D. T., Phan, H. T. T., Phillips, P. P. J., Ruiz, J., Rupasinghe, Praharshinie, Salahuddin, N., Sanchez-Garavito, E., Seung, K. J., Asfaw, M. T., Vargas Vasquez, D., Rich, M. L., Varaine, F., Mitnick, C. D., Arora, G., Ashara, V., Bhattacharjee, S., Borkar, R., Chincholikar, N., Choudhary, N., Davuluri, P., Desai, N., Dipika, Dhongade, S., Dulani, D., Ghule, S., Hirani, N., Hurali, P., Irani, R., Jadhav, K., Jadhav, P., Jadhav, R., Joseph, N., Joshi, A., Joshi, P., K, A., K, S., Kamble, M., Kate, R., Keer, T., S Kenche, M., Khandare, H., Koli, P., Kulkarni, A., Patra, S. K., Kuwar, A., Lande, P., Mane, N., Masalge, P., Mishra, P., Mitkari, R., More, A., Munot, P., Murgesh, R., Muthe, S., Nakashe, N., Natarajan, D., Paril, S., Patil, Supriya, Patil, V., Patwardhan, V., Posture, V., Pradeshi, A., Prasad, V., Pundir, B., Rajendran, S., Randhit, Y., Rekart, M., Samant, P., Shaikh, H., Sharma, A., Sharma, N., Sharma, S., Shinde, N., Shinde, S., Shingare, G., Shulka, A., Shriwas, A., Sonawane, L., Sudhindra, U., Suryavanshi, D., Thakare, A., Udare, D., Vaidya, G., Wagh, R., Isenova, L., Konigratbayeva, G., Nurtayeva, G., Zekeshov, N., Chenu, R., Garba, S., Tozzi, D., Yuya-Septoh, F.-J., Thi Tuyet Mai, B., Thi Hai, D., Thi Thuy, D., Thi Oanh, L., Do, B. T., Nguyen, D. T., Nguyen, P. H., Nguyen, T. M. A., Nguyen, Thi Thuy Hanh, Nguyen, T. K. N., Nguyen, T. N., Nguyen, V. K., Nog, N., Pham, T. N., Pham, T. L., Pham, T. A., Phung, T. B., Tran, B. T., Trinh, M. T., Chang, E., Coit, J., Do, J.-M., LaHood, A., O’Brien, K., Okunbor, E., Osso, E., Chávez, V., Larco, P., Mendoza, D., Robles, C., Rojas, A., Salazar, J., Santos, G., Sosa, J., Ticona, C., Carranza, S., Delgado, D., Galarza, C., Murga, G., Ramos, E., Cantaro, K., Huerta, A., Maldonado, J., Nuñez, R., Panduro, K., Rafael, R., Abdul, A., Abedin, S., Afreen, E., Ahmed, Sohail, Ahmed, U., Ali Shah, J., Ashraf, A., Aslam, F., Bashir, Z., Fayyaz, S., Hafeez, K., Hamid, M., Hassan, B., Hussain, M., Irfan, M., Omar, M., Parveen, S., Sunail, S., Farooq, M., Mazhar, B., Munir, S., Sonia, N., Yaseen, M., Zubair, M., Zehra, F., Zulfiqar, I., Abbasi, T., Akbar Abro, G., Ahmed, M., Ahmed, N., Hammad Ali, M., Ali, N., Danish, R., Farhat, A., Gill, S., Hafeez, M., Hussain, G., Inayat, H., Johnson, S., Kamal, F., Kamran, A., Kumar, Sanjeet, Maheshwari, M., Mamsa, S., Massey, S., Mehmood, A., Memon, A., Ali Mirani, A., Naz, S., Rafique Qureshi, T., Roop Moazzam Sheikh, Y., Rafi Siddiqui, M., Singh, B., Soomro, M., Ardizzoni, E., Rigouts, L., Rupasinghe, Praha, Aftab, A., Ahmed, Saman, Adnan Alamgir, M., Ali, Ayaz, Ali, Azhar, Ahmed Ali, S., Ali, S., Altaf, S., Amjad, S., Sahiba Arshad, M., Ausim, S., Basit, A., Ezik, H., Hussain, H., Hyder, S., Inayat, S., Janmohammed, A., Jaseem, K., Jawed, A., Maniar, L., Kumar, P., Kumar, Susheel, Latif, R., Liaqat, S., Ammar Nasser, M., Shakeel, M., Shaikh, S., Siddiqui, A., Singh, J., Sivan, K., Taimoor, M., Zia, N., Li, I., Otepbergenova, M., Dinh, T. H., Do, Thi Thu, Do, Thu Thuong, Le, T. N., Nguyen, K. C., Nguyen, T. T., Nguyen, V. H., Abildayeva, G., Maryash, O., Telegina, E., Tursynbekova, L., Amanzholova, Z., Bektassova, P., Belgozhanova, A., Birimkulova, N., Dyusebayeva, N., Erkut, N., Gusmanov, A., Kassenova, B., Kassym, A., Khazhidinov, K., Lee, T., Magzumova, A., Mussabayeva, M., Omarova, G., Ryapolova, N., Sagyndykova, L., Serekbay, A., Stambekova, A., Tanatarova, G., Uaisov, Z., Zhantuarova, Z., Zhumakairova, G., Arlyapova, N., Bogus, J., Cain, M., Carmona, M., Flanagan, C., McAnaw, S., Scharff, A., Soni, S., Striplin, M., Abebe, S., Alakaye, J., Bulane, A., Custodio, M., Hajison, P., Hetsa, M., Holtzman, D., Khesa, M., Lethola, M., Lebitsa, T., Mahamo, M., Makaka, J., Matoko, M., Mpinda, S., Mohoang, P., Monyaesa, D., Nkundayirazo, P., Ntsane Sesomo Mohale, M., Ntsibane, S., Phate, S., Radebe (Retsepile Tlali), M., Rakhetsi, M., Ranoosi, T., Tamirat, M., Thokoana, M., Alegre, E., Aguilar, C., Armuto, L., Barreda, N., Barreto, M., Cabrera, S., Calderon, R., Castro, M., Chavez, J., Chavez, L., Cheje, H., Cori, L., Dávalos, D., de la Gala, S., Delgadillo, K., Diaz, H., Flores, X., Galarza, J., García, D., Garcia, F., Gaspar, M., Godos, R., Gomez, P., Gonzales, L., Guerrero, L., Inga, S., Jasaycucho, J., Martel, B., Pro Martinez, A., Molina, R., Mugruza, R., Mundaca, H., Nuahan, M., Ore, K., Panduro, L., Peña, O., Perea, S., Pinedo, C., Ponce, Y., Quinte, C., Quiñones, M., Ramos, A., Ramirez, E., Reynoso, R., Reyes, C., Reyes, J., Riccio, V., Robles, B., Rojas, K., Sanabria, O., Saravia, M., Saravia, S., Senador, L., Soberon, J., Soncco, E., Soto, M., Suarez, C., Suarez, M., Suarez, V., Torpoco, E., Torres, O., Torrez, C., Tunque, G., Ugarte, A., Vaderrama, G., Valdivia, W., Valdivia, Y., Valverde, I., Vargas, C., Vargas, J., Vasquez, E., Veliz, J., Villa, D., Villafuerte, S., Villar, G., Villegas, S., Wong, M., Yataco, R., Pham, H., Truong, H., Nguyen, H., Huy, V., Nguyen, V. S., Nguyen, T. M. K., Minh, T., Bui, D. T. T., Truong, V. V., Nguyen, Thi Thu Ha, Coutisson, S., Atger, M., Nadia Baya, S., Bekhiet, M., Boissière, V., Caboclo, R., Chaudhry, M., Cloez, S., Collin, S., Delifer, C., Demaisons, S., Ducher, V., Hewison, C., Ibrahim, M., Lebeau, K., Mazmanian, M., Mirzayeva, R., Moreau, M., Moschioni, M., Pâquet, A., Perrin, C., Pichon, L., Roussel, J., Scotton, M., Austin, A. and Sun, P. (2025). Bedaquiline, delamanid, linezolid, and clofazimine for rifampicin-resistant and fluoroquinolone-resistant tuberculosis (endTB-Q): an open-label, multicentre, stratified, non-inferiority, randomised, controlled, phase 3 trial. The Lancet Respiratory Medicine, http://doi.org/10.1016/S2213-2600(25)00194-8.
Guthmann, J.-P., Robert, J., Viriot, D. and Parent Du Chatelet, I. (2025). Incidence, severity and treatment outcome of tuberculosis in the era of the COVID-19 pandemic, France, 2018–2023. Journal of Epidemiology and Population Health 73, 202795, http://doi.org/10.1016/j.jeph.2024.202795.
Hillemann, D., Cambau, E., Polsfuß, S. and Friesen, I. (2025). Comparison of a modified broth microdilution SensititreTM SLOMYCOI assay with the CLSI-recommended agar disk elution method for antimicrobial susceptibility testing of Mycobacterium haemophilum. Journal of Antimicrobial Chemotherapy 80, 1993–1996, http://doi.org/10.1093/jac/dkaf162.
Kherabi, Y., Skouvig Pedersen, O., Lange, C., Bénézit, F., Chesov, D., Codecasa, L. R., Dudnyk, A., Kiria, N., Konstantynovska, O., Marigot-Outtandy, D., Panciu, T.-C., Poignon, C., Sasi, S., Schaub, D., Solodovnikova, V., Vasiliauskaitè, L., Yeghiazaryan, L., Günther, G., Guglielmetti, L. and TBnet/ESGMYC XDR-TB Study Group (2025). Treatment outcomes of extensively drug-resistant tuberculosis in Europe: a retrospective cohort study. Lancet Reg Health Eur 56, 101380, http://doi.org/10.1016/j.lanepe.2025.101380.
Kuksa, L., Andrejak, C., Haecker, B., Bothamley, G., Calcagno, A., Cirillo, D. M., Duarte, R., Fatima, R., Ferlazzo, G., Guglielmetti, L., Günther, G., Hewison, C., Horsburgh, C. R., Jäger, T., Kalancha, Y., Otto-Knapp, R., Kranzer, K., Lillebaek, T., Marks, G., Middelkoop, K., Motta, I., Rabinova, V., Sommerfeld, P., Tattevin, P. and Lange, C. (2025). Urgent request for pretomanid label expansion to align with WHO guidelines and improve treatment accessibility and efficacy. IJTLD OPEN 2, 117–119, http://doi.org/10.5588/ijtldopen.25.0152.
Lange, C., Bothamley, G., Günther, G., Guglielmetti, L., Kontsevaya, I., Kuksa, L., Lange, B., Lorent, N., Saluzzo, F., Sester, M., Tebruegge, M., Tunesi, S. and Tweed, C. (2025). A Year in Review on Tuberculosis and Non-tuberculous Mycobacteria Disease: A 2025 Update for Clinicians and Scientists. PAI 10, 1–45, http://doi.org/10.20411/pai.v10i2.791.
Méchaï, F., Beugre, E., Billard-Pomares, T., Mougari, F., Wyplosz, B., Cambau, E. and Vignier, N. (2025). Usefulness of the GeneXpert MTB/RIF Ct for predicting tuberculosis infectiousness. Infectious Diseases Now 55, 105061, http://doi.org/10.1016/j.idnow.2025.105061.
Sadowski, E., Pietrancosta, N., Veyron-Churlet, R., Boucher, J.-L., Pionneau, C., Clodic, G., Matheron, L., Poch, O., Mayer, C., Sachon, E. and Aubry, A. (2025). Characterization of the Orphan Cytochrome P450 CYP135B1 from Mycobacterium tuberculosis : Involvement in Metabolism but Not in the Antibacterial Activity of the Antitubercular Drug SQ109. ACS Infect Dis 11, 869–881, http://doi.org/10.1021/acsinfecdis.4c00893.
Seddon, J. A., Achar, J., Malik, A. A., Hughes, J., Burzynski, J., Chen, C., Denholm, J. T., Dravniece, G., Fox, G. J., Furin, J., Geliukh, E., Goncharova, O., Guglielmetti, L., Harries, A. D., Hesseling, A. C., Nguyen, B. H., Kavenga, F., Khan, U., Kherabi, Y., Kiria, N., Kock, Y., Liu, Q., Mesic, A., Moore, D. A. J., Mubanga, A., Naidoo, L., Nilsen, D., Piubello, A., Reuter, A., Rich, M. L., Satyanarayana, S., Schaaf, H. S., Schoeman, I., Skrahina, A., Udwadia, Z., Khan, P. Y., Esmail, H. and Martinez, L. (2025). Management of individuals exposed to multidrug-resistant or rifampicin-resistant tuberculosis. The Lancet Infectious Diseases, http://doi.org/10.1016/S1473-3099(25)00157-4.
Serge Diagbouga, P., Djibougou, A. D., Pease, C., Alcaide, A., Berthoux, A., Bruiners, N., Cirillo, D. M., Combary, A., Falchero, N., Handler, D., Kaboré, A., Lardizabal, A., Lopes, A., Loubet, M., Manivet, P., Margain, C., Meunier, V., Mougari, F., Onyuka, A., Rivoiron, S., Sagna, T., Sanvert, M., Sawadogo, L., Simporé, J., Cambau, E. and Gennaro, M. L. (2025). Preliminary performance of the VIDAS TB-IGRA as an aid in the diagnosis of individuals infected with Mycobacterium tuberculosis Ed. Miller, M. B. J Clin Microbiol 63, e01641-24, http://doi.org/10.1128/jcm.01641-24.
Soutou, M. A., Allam, C., Abi Fadel, M., Najjar, J., Guyeux, C., Cambau, E. and Sola, C. (2025). An insight into the characterization of L2 Beijing multi-drug resistant tuberculosis: Description of resistance-associated-variants and discovery of Modern 7 L2 sublineage. Infection, Genetics and Evolution 134, 105797, http://doi.org/10.1016/j.meegid.2025.105797.
Verma, A. K., Kim, R. Q., Lamprecht, D. A., Aguilar-Pérez, C., Wong, S., Veziris, N., Aubry, A., Bartolomé-Nebreda, J. M., Carbajo, R. J., Wetzel, J. and Lamers, M. H. (2025). Structural and mechanistic study of a novel inhibitor analogue of M. tuberculosis cytochrome bc1:aa3. npj Drug Discov 2, 6, http://doi.org/10.1038/s44386-025-00008-3.